<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">99426</article-id><article-id pub-id-type="doi">10.7554/eLife.99426</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.99426.5</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Functional genomics reveals strain-specific genetic requirements conferring hypoxic growth in <italic>Mycobacterium intracellulare</italic></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Tateishi</surname><given-names>Yoshitaka</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1200-0000</contrib-id><email>y-tateishi@med.niigata-u.ac.jp</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ozeki</surname><given-names>Yuriko</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0672-1039</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Nishiyama</surname><given-names>Akihito</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4416-7710</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Morishige</surname><given-names>Yuta</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3818-5288</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Minato</surname><given-names>Yusuke</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0888-8564</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Baughn</surname><given-names>Anthony David</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1188-4238</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Matsumoto</surname><given-names>Sohkichi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6106-7538</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04ww21r56</institution-id><institution>Department of Bacteriology, Graduate School of Medicine and Dental Sciences, Niigata University</institution></institution-wrap><addr-line><named-content content-type="city">Niigata</named-content></addr-line><country>Japan</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012eh0r35</institution-id><institution>Department of Microbiology, Fukushima Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Fukushima</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012daep68</institution-id><institution>Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association</institution></institution-wrap><addr-line><named-content content-type="city">Kiyose</named-content></addr-line><country>Japan</country></aff><aff id="aff4"><label>4</label><institution>Center for Infectious Disease Research, Fujita Health University</institution><addr-line><named-content content-type="city">Toyoake</named-content></addr-line><country>Japan</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/017zqws13</institution-id><institution>Department of Microbiology and Immunology, University of Minnesota Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Medical Microbiology, Faculty of Medicine, Universitas Airlangga</institution><addr-line><named-content content-type="city">Surabaya</named-content></addr-line><country>Indonesia</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01hvx5h04</institution-id><institution>Department of Bacteriology, Osaka Metropolitan University Graduate School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Osaka</named-content></addr-line><country>Japan</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02e16g702</institution-id><institution>Division of Research Aids, Hokkaido University Institute for Vaccine Research and Development</institution></institution-wrap><addr-line><named-content content-type="city">Sapporo</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Singh</surname><given-names>Amit</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04dese585</institution-id><institution>Indian Institute of Science</institution></institution-wrap><country>India</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rp50x72</institution-id><institution>University of the Witwatersrand</institution></institution-wrap><country>South Africa</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>23</day><month>12</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP99426</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-05-13"><day>13</day><month>05</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-05-13"><day>13</day><month>05</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.05.12.593797"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-07-16"><day>16</day><month>07</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.99426.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-09-22"><day>22</day><month>09</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.99426.2"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-11-20"><day>20</day><month>11</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.99426.3"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-12-09"><day>09</day><month>12</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.99426.4"/></event></pub-history><permissions><copyright-statement>© 2024, Tateishi et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Tateishi et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-99426-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-99426-figures-v1.pdf"/><abstract><p><italic>Mycobacterium intracellulare</italic> is a major etiological agent of the recently expanding <italic>Mycobacterium avium–intracellulare</italic> complex pulmonary disease (MAC-PD). Therapeutic regimens that include a combination of macrolides and antituberculous drugs have been implemented with limited success. To identify novel targets for drug development that accommodate the genomic diversity of <italic>M. avium–intracellulare</italic>, we subjected eight clinical MAC-PD isolates and the type strain ATCC13950 to genome-wide profiling to comprehensively identify universally essential functions by transposon sequencing (TnSeq). Among these strains, we identified 131 shared essential or growth-defect-associated genes by TnSeq. Unlike the type strain, the clinical strains showed increased requirements for genes involved in gluconeogenesis and the type VII secretion system under standard growth conditions, the same genes required for hypoxic pellicle-type biofilm formation in ATCC13950. Consistent with the central role of hypoxia in the evolution of <italic>M. intracellulare</italic>, the clinical MAC-PD strains showed more rapid adaptation to hypoxic growth than the type strain. Importantly, the increased requirements of hypoxic fitness genes were confirmed in a mouse lung infection model. These findings confirm the concordant genetic requirements under hypoxic conditions in vitro and hypoxia-related conditions in vivo and highlight the importance of using clinical strains and host-relevant growth conditions to identify high-value targets for drug development.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>nontuberculous mycobacteria</kwd><kwd>transposon sequencing</kwd><kwd>hypoxia</kwd><kwd>gene requirements</kwd><kwd>gene essentiality</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03mwa7s65</institution-id><institution>Ministry of Health Labour and Welfare</institution></institution-wrap></funding-source><award-id>20KK0216</award-id><principal-award-recipient><name><surname>Tateishi</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03mwa7s65</institution-id><institution>Ministry of Health Labour and Welfare</institution></institution-wrap></funding-source><award-id>21K19637</award-id><principal-award-recipient><name><surname>Tateishi</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03mwa7s65</institution-id><institution>Ministry of Health Labour and Welfare</institution></institution-wrap></funding-source><award-id>22H03115</award-id><principal-award-recipient><name><surname>Tateishi</surname><given-names>Yoshitaka</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/048rj2z13</institution-id><institution>Ministry of Education, Culture, Sports, Science and Technology</institution></institution-wrap></funding-source><award-id>23fk0108673h0501</award-id><principal-award-recipient><name><surname>Matsumoto</surname><given-names>Sohkichi</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/004rtk039</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>25gm1610009h0004</award-id><principal-award-recipient><name><surname>Matsumoto</surname><given-names>Sohkichi</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/004rtk039</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>JP223fa627005</award-id><principal-award-recipient><name><surname>Matsumoto</surname><given-names>Sohkichi</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/004rtk039</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>JP23gm1610013</award-id><principal-award-recipient><name><surname>Minato</surname><given-names>Yusuke</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hhkn466</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>23K27325</award-id><principal-award-recipient><name><surname>Minato</surname><given-names>Yusuke</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hhkn466</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>24K1163</award-id><principal-award-recipient><name><surname>Minato</surname><given-names>Yusuke</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Transposon sequencing analyses reveal that among genomically diverse clinical <italic>Mycobacterium intracellulare</italic> strains and the type strain, 131 genes were comprehensively identified as universal essential genes suggesting promising drug targets.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>In contrast to the ongoing decline in the rate of tuberculosis, <italic>Mycobacterium avium–intracellulare</italic> complex pulmonary disease (MAC-PD) is increasing in many parts of the world (<xref ref-type="bibr" rid="bib1">Adjemian et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Namkoong et al., 2016</xref>). The standard therapy for MAC-PD involves multidrug chemotherapy that includes clarithromycin and several antituberculous drugs. Unfortunately, treatment failure is common, resulting in relapse, disease progression, and death (<xref ref-type="bibr" rid="bib12">Daley et al., 2020</xref>). Therefore, it is critical to investigate the bacterial physiological characteristics that underlie the ability of MAC-PD strains to establish and maintain chronic drug-recalcitrant infections.</p><p>Recent advances in comparative genomics have revealed major differences in the genomic features of reference type strains and circulating pathogenic clinical isolates. Extensive genomic diversity has been recognized across clinical isolates of nontuberculous mycobacteria (NTM). <italic>Mycobacterium avium</italic> has been divided into four subspecies, including subspecies <italic>avium</italic>, <italic>hominissuis</italic>, <italic>silvaticum</italic>, and <italic>paratuberculosis</italic> (<xref ref-type="bibr" rid="bib58">Uchiya et al., 2017</xref>). Whereas <italic>M. intracellulare</italic> has been divided into two subgroups, typical <italic>M. intracellulare</italic> (TMI) and <italic>M. paraintracellulare–M. indicus pranii</italic> (MP-MIP), with currently two additional distinguished subspecies, <italic>yongonense</italic> and <italic>chimaera</italic> (<xref ref-type="bibr" rid="bib54">Tateishi et al., 2021</xref>; <xref ref-type="bibr" rid="bib57">Tortoli et al., 2019</xref>). Despite the increasing number of sequenced MAC-PD strains, the molecular genetic mechanisms that underlie their virulence and pathogenesis are still poorly understood.</p><p>The burgeoning field of functional genomics has allowed the rapid assessment of molecular aspects of organisms on a genome-wide scale. Transposon (Tn) sequencing (TnSeq) is a functional genomic approach that combines saturation-level transposon-insertion mutagenesis with next-generation sequencing (NGS) to comprehensively evaluate the fitness costs associated with gene inactivation in bacteria. Over the last decade, TnSeq has been applied to numerous bacterial species using various approaches (<xref ref-type="bibr" rid="bib59">van Opijnen and Camilli, 2013</xref>). Whereas initial studies applied TnSeq to reference strains, recent approaches have included the comparative assessment of representative clinical strains to better understand the fundamental aspects of pathogen biology (<xref ref-type="bibr" rid="bib6">Carey et al., 2018</xref>; <xref ref-type="bibr" rid="bib2">Akusobi et al., 2025</xref>). We have previously used TnSeq to globally characterize the genes that are essential for growth versus those that are essential for hypoxic pellicle formation in the <italic>M. intracellulare</italic> type strain ATCC13950 (<xref ref-type="bibr" rid="bib53">Tateishi et al., 2020</xref>). However, given the recent expansion of MAC-PD and the well-recognized high levels of genomic diversity in this complex of bacteria, data obtained from the study of a decades-old reference strain is not expected to represent the diversity of extant clinical isolates. ATCC13950 was originally isolated from the abdominal lymph node of the 34-month-old female (<xref ref-type="bibr" rid="bib11">Cuttino and McCABE, 1949</xref>). Even though the etiological bacterial species are the same, the clinical manifestation of infant lymphadenitis differs markedly from MAC-PD, which often occurs in middle-aged and elderly female patients with no predisposing immunological disorder. So far, there are a total of two reports on TnSeq that compare genetic requirements between clinical mycobacterial strains and the type strains in <italic>M. tuberculosis</italic> (<xref ref-type="bibr" rid="bib6">Carey et al., 2018</xref>) and <italic>M. abscessus</italic> (<xref ref-type="bibr" rid="bib2">Akusobi et al., 2025</xref>). They reported the diversity of genetic requirements among strains, including the type strain, such as <italic>M. tuberculosis</italic> H37Rv and <italic>M. abscessus</italic> ATCC19977. Therefore, it is essential to investigate a collection of strains that captures the diversity of recent clinical MAC-PD strains in order to define key molecular aspects of their pathogenesis and virulence.</p><p>In this study, we used TnSeq to analyze a set of recently isolated clinical <italic>M. intracellulare</italic> strains with diverse genotypes. We integrated the gene essentiality data for these strains and the type strain to identify the common essential and growth-defect-associated genes that represent the genomic diversity of this group of pathogens. We also identified the greater requirements of genes involved in gluconeogenesis, the type VII secretion system, and cysteine desulfurase in the clinical MAC-PD strains than in the type strain. Furthermore, the requirement for these genes was confirmed in a mouse lung infection model. The profiles of genetic requirements in clinical MAC-PD strains suggest the mechanism of hypoxic adaptation in NTM in terms of promising drug targets, especially for strains that cause clinical MAC-PD.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Common essential and growth-defect-associated genes representing the genomic diversity of <italic>M. intracellulare</italic> strains</title><p>To obtain comprehensive information on the genome-wide gene essentiality of <italic>M. intracellulare</italic>, we included nine representative strains of <italic>M. intracellulare</italic> with diverse genotypes for TnSeq in vitro in this study (<xref ref-type="fig" rid="fig1">Figure 1a and b</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). We used TRANSIT (<xref ref-type="bibr" rid="bib13">DeJesus et al., 2015</xref>) to obtain 2–6 million reads of Tn insertions. The average number of Tn insertion reads was &gt;50 at Tn-inserted TA sites, which confirmed the TnSeq data (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). The numbers of essential genes in the clinical MAC-PD strains, calculated with the hidden Markov model (HMM; a transition probability model), tended to be smaller than that in ATCC13950 (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). In total, 131 genes were identified as essential or growth-defect-associated with the HMM analysis across all <italic>M. intracellulare</italic> strains, including the eight MAC-PD clinical strains and ATCC13950 (<xref ref-type="fig" rid="fig2">Figure 2a</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). The genes identified as universal essential or growth-defect-associated were involved in fundamental functions, such as glyoxylate metabolism, purine/pyrimidine metabolism, amino acid synthesis, lipid biosynthesis, arabinogalactan/peptidoglycan biosynthesis, porphyrin metabolism, DNA replication, transcription, amino acid tRNA ligases, ribosomal proteins, general secretion proteins, components of iron–sulfur cluster assembly, some ABC transporters, and the type VII secretion system. The genes identified corresponded to the genes that encode conventional and under-development drug targets, such as those encoding gyrase, arabinosyltransferase, enoyl-(acyl-carrier-protein) reductase, alanine racemase, DNA-directed RNA polymerase, malate synthase (<xref ref-type="bibr" rid="bib24">Krieger et al., 2012</xref>), and F<sub>0</sub>F<sub>1</sub> ATP synthase (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). These data suggest that the set of universal essential or growth-defect-associated genes identified with the HMM analysis of <italic>M. intracellulare</italic> strains with diverse genotypes has potential utility as antibiotic drug targets.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Phylogenetic tree of the <italic>M</italic>. <italic>intracellulare</italic> strains and strategy of the Transposon sequencing (TnSeq) analyses in this study.</title><p>(<bold>a</bold>) Phylogenetic tree of the <italic>M. intracellulare</italic> strains used in this study. The tree was generated based on average nucleotide identity (ANI) with the neighbor-joining method. TMI: typical <italic>M. intracellulare</italic>; MP-MIP: <italic>M. paraintracellulare–M. indicus pranii</italic>. The detail of the phylogenetic tree is shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>. (<bold>b</bold>) Strategy of the procedure of TnSeq analyses.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Subject <italic>M</italic>. <italic>intracellulare</italic> strains in this study.</title><p>The phylogenetic tree represents the global genetic diversity of the <italic>M. intracellulare</italic> strains by our previous study (<xref ref-type="bibr" rid="bib54">Tateishi et al., 2021</xref>). The subject strains were squared in red. As for strains squared in bold line, four strains, including the type strain ATCC13950 were selected from the TMI (typical <italic>M. intracellulare</italic>) group, and five strains were selected from the MP-MIP (<italic>M. paraintracellulare-M. indicus pranii</italic>) group in this Transposon sequencing (TnSeq) study. Two strains squared in dashed lines are closely related neighbors of ATCC13950, which were additionally enrolled in the hypoxic growth assay (as explained in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig1-figsupp1-v1.tif"/></fig></fig-group><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Identification of the essential and growth-defect-associated genes across genetically diverse nine <italic>M</italic>. <italic>intracellulare</italic> strains used in this study.</title><p>(<bold>a</bold>) Functional categories of 131 genes identified as universal essential or growth-defect-associated with an hidden Markov model (HMM) analysis. The genes were categorized according to the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. (<bold>b</bold>) Universal essential or growth-defect-associated genes corresponding to the genes of existing antituberculous drug targets. (<bold>c</bold>) The number of the essential or growth-defect-associated genes in the accessory genes, and the number of strain-dependent essential or growth-defect-associated genes in the core genes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Summary of the gene set enrichment analysis (GSEA) results.</title><p>The dataset of strain-dependent/accessory essential or growth-defect-associated genes was statistically tested to be enriched with the gene sets required for hypoxic pellicle formation observed in ATCC13950. (Top) Statistics data for the gene set enrichment analysis. (Bottom) Data of enrichment plots. On the X-axis, the left direction indicates positive correlation with the gene sets required for hypoxic pellicle formation observed in ATCC13950, and the right direction indicates negative correlation with the gene sets required for hypoxic pellicle formation observed in ATCC13950. Only 31 genes were ranked because the rest of the 144 genes were not present in the gene sets of strain-dependent or accessory essential genes. The ranking of the genes in the gene sets required for hypoxic pellicle formation observed in ATCC13950 is shown in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig2-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>The sharing of strain-dependent and accessory essential and growth-defect-associated genes with genes required for hypoxic pellicle formation in the type strain ATCC13950</title><p>By comparative genomic analysis, we have revealed 3153 core genes among 55 <italic>M</italic>. <italic>intracellulare</italic> strains, including those used in this study (<xref ref-type="bibr" rid="bib54">Tateishi et al., 2021</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Of these core genes, 439 genes were classified as strain-dependent essential or growth-defect-associated with the HMM analysis (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). And among 5824 accessory genes, 222 genes were classified as essential or growth-defect-associated with the HMM analysis. The proportion of these strain-dependent and accessory essential or growth-defect-associated genes was comparable to the similar analysis of <italic>Streptococcus pneumoniae</italic> (<xref ref-type="bibr" rid="bib45">Rosconi et al., 2022</xref>). Of note, 17 (3.8%) of strain-dependent essential or growth-defect-associated genes and 14 (6.3%) of accessory essential or growth-defect-associated genes were also included in the 175 genes required for hypoxic pellicle formation in ATCC13950 reported in our previous study (<xref ref-type="bibr" rid="bib53">Tateishi et al., 2020</xref>; <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). Gene set enrichment analysis (GSEA) (<xref ref-type="bibr" rid="bib51">Subramanian et al., 2005</xref>) showed that 9.1% (16 out of 175) genes were hit as core enrichment (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). Of them, four genes were hit commonly as genes showing increased genetic requirements analyzed by resampling plus HMM analyses, including genes of phosphoenolpyruvate carboxykinase <italic>pckA</italic> (OCU_RS48660), type VII secretion-associated serine protease <italic>mycP5</italic> (OCU_RS38275), type VII secretion protein eccC5 (OCU_RS38345) and glycine cleavage system amino-methyltransferase <italic>gcvT</italic> (OCU_RS35955).</p></sec><sec id="s2-3"><title>Partial overlap of the genes showing increased genetic requirements in clinical MAC-PD strains with those required for hypoxic pellicle formation in the type strain ATCC13950</title><p>The profiles of genetic requirements in each bacterial strain reflect the adaptation to the environment in which each strain lives. When the strains are placed in a special environment, they can adapt to the situation by altering the profiles of genetic requirements, resulting in the remodeling of metabolic pathways. The sharing of strain-dependent and accessory essential or growth-defect-associated genes with genes required for hypoxic pellicle formation in ATCC13950 prompts us to consider that the profiles of genetic requirements in clinical MAC-PD strains may be associated with the genes required for hypoxic pellicle formation in ATCC13950. To clarify this, we compared the genetic requirements of the clinical MAC-PD strains with that in ATCC13950 by integrating the HMM analysis with the resampling analysis, a method of calculating the number of significantly altered Tn insertion reads (a gene-based permutation model). With this integrating analysis, 121 genes in the clinical MAC-PD strains were shown to have significantly fewer Tn insertions than ATCC13950 (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="supplementary-material" rid="supp7 supp8">Supplementary files 7 and 8</xref>). Of these, nine genes were identified in 3–5 clinical MAC-PD strains. These included genes encoding phosphatases (OCU_RS30185, OCU_RS35795), cysteine desulfurase (<italic>csd</italic> [OCU_RS40305]), methyl transferase (OCU_RS41540), a hypothetical protein (OCU_RS47290), type VII secretion components (<italic>mycP5</italic> [OCU_RS38275], <italic>eccC5</italic> [OCU_RS38345]), a glycine cleavage system aminomethyltransferase (<italic>gcvT</italic> [OCU_RS35955]), and phosphoenolpyruvate carboxykinase (<italic>pckA</italic> [OCU_RS48660]) (<xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig4">Figure 4</xref>). The genes involved in gluconeogenesis (such as <italic>pckA</italic>), the glycine cleavage system, and the type VII secretion system were also identified as required for hypoxic pellicle formation in ATCC13950 in our previous study (<xref ref-type="bibr" rid="bib2">Akusobi et al., 2025</xref>). The Tn insertion reads were significantly reduced in the pathways of gluconeogenesis, including in fructose-1,6-bisphosphatase (<italic>glpX</italic>), phosphoenolpyruvate carboxykinase (<italic>pckA</italic>), and pyruvate carboxylase (<italic>pca</italic>), but were significantly increased in those of glycolysis, including in pyruvate kinase (<italic>pykA</italic>) and pyruvate dehydrogenase (<italic>aceE</italic>, <italic>lpdC</italic>), suggesting that carbohydrate metabolism was metabolically remodeled in the clinical MAC-PD strains, which mimics the metabolism observed during hypoxic pellicle formation in ATCC13950 (<xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Detection of genes showing increased or reduced genetic requirements in the clinical <italic>M</italic>. <italic>intracellulare</italic> strains.</title><p>Left panel shows the genes identified as having fewer transposon (Tn) insertion reads than the type strain ATCC13950. The fold changes in the number of Tn insertion reads calculated by a resampling analysis are represented by the color scale. Red squares indicate genes required for hypoxic pellicle formation in ATCC13950 (<xref ref-type="bibr" rid="bib53">Tateishi et al., 2020</xref>). *Genes identified with a combination of resampling and hidden Markov model (HMM) analyses. †Genes identified only with resampling analysis. Right panel shows the genes identified as having more Tn insertion reads than the type strain ATCC13950. NH: no homolog with ATCC13950, NS: no significant increase in Tn insertion reads by a resampling analysis (adjusted <italic>p</italic>&lt;0.05).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig3-v1.tif"/></fig><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Overview of the differences in genetic requirements between the clinical <italic>M</italic>. <italic>intracellulare</italic> strains and ATCC13950, drawn with Cytoscape (<xref ref-type="bibr" rid="bib49">Shannon et al., 2003</xref>).</title><p>Each central node represents the functional category of genes, assigned with a Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Each peripheral node represents the genes showing significant changes in the number of Tn insertion reads. The size of each node represents the number of strains identified. Each edge represents a strain identified as showing significant changes in the number of transposon (Tn) insertion reads. The thickness of each edge represents the adjusted <italic>p</italic> value. The color scale of each edge represents the fold change in the number of Tn insertion reads calculated by a resampling analysis. The graphical organization was referenced to the previous publication by <xref ref-type="bibr" rid="bib6">Carey et al., 2018</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig4-v1.tif"/></fig><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Preferential genetic requirements for gluconeogenesis in the clinical <italic>M</italic>. <italic>intracellulare</italic> strains inferred from the Transposon sequencing (TnSeq) results.</title><p>(<bold>a</bold>) Carbohydrate pathway showing the changes in Tn insertion reads. Genes identified with the resampling analysis are framed by squares. The essentiality of gluconeogenesis-related genes (<italic>pckA, glpX</italic>) was higher and that of glycolysis-related genes (<italic>aceE, lpdC</italic>) was lower in the clinical <italic>M. intracellulare</italic> strains compared with those in ATCC13950. (<bold>b</bold>) Data on genetic requirements calculated with a resampling analysis in the clinical <italic>M. intracellulare</italic> strains compared with ATCC13950. Red indicates a reduction in transposon (Tn) insertion reads in the clinical <italic>M. intracellulare</italic> strains. Blue indicates an increase of Tn insertion reads in the clinical <italic>M. intracellulare</italic> strains. Asterisks indicate statistical significance of log<sub>2</sub> fold changes (log<sub>2</sub>FCs). The graphical organization was referenced to the previous publication by <xref ref-type="bibr" rid="bib6">Carey et al., 2018</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig5-v1.tif"/></fig></sec><sec id="s2-4"><title>Minor role of gene duplication on reduced genetic requirements in clinical MAC-PD strains</title><p>On the other hand, 162 genes were detected with significantly more Tn insertions in the clinical MAC-PD strains than in ATCC13950 (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Of these, 12 genes were identified in more than seven strains. The increased Tn insertion reads in the genes encoding superoxide dismutase (OCU_RS25945) and pyruvate dehydrogenase (<italic>aceE</italic> [OCU_RS35720]) in the clinical MAC-PD strains suggest the inessentiality of the detoxification of oxygen radicals and glycolysis metabolism in these strains (<xref ref-type="fig" rid="fig3">Figures 3</xref>—<xref ref-type="fig" rid="fig5">5</xref>). These genes also included those encoding amidohydrolases (OCU_RS34400, OCU_RS34425, OCU_RS34445), some transcription factors (OCU_RS28440, OCU_RS30230), a CoA transferase (OCU_RS34390), and some predicted transporters (OCU_RS28435, OCU_RS39950, OCU_RS39955, OCU_RS44685). Furthermore, the increase in Tn insertion reads in predicted multidrug-resistant genes, such as those encoding the DrrAB-ABC transporter complex (OCU_RS39950, OCU_RS39955) (<xref ref-type="bibr" rid="bib9">Coll et al., 2018</xref>) and a putative lipoprotein LpqB (OCU_RS44685), encoded by the two-component system <italic>mtrAB</italic> operon (<xref ref-type="bibr" rid="bib37">Nguyen et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Li et al., 2022</xref>), in the clinical MAC-PD strains were found.</p><p>In order to investigate the effect of gene duplication on the change of genetic requirements between strains, we conducted a BLAST search for the 162 genes showing increased Tn insertion reads in the clinical MAC-PD strains compared to ATCC13950. We found that M019 has duplicate genes of OCU_RS44705 coding adenosylhomocysteinase (LOCUS_42940: ahcY_1, LOCUS_21000: ahcY_2). However, there were no duplicate genes found in the remaining 161 genes. These data suggest that gene duplication has minor effects on the change of genetic requirements between strains. Rather, sequence differences and accessory genes may play a key role in determining the difference in genetic requirements.</p></sec><sec id="s2-5"><title>Identification of genes in the clinical MAC-PD strains required for mouse lung infection</title><p>Hypoxia is the major environmental condition in natural water (<xref ref-type="bibr" rid="bib22">Kirschner et al., 1992</xref>), biofilms (<xref ref-type="bibr" rid="bib62">Werner et al., 2004</xref>), and infections in humans and animals characterized by caseous granuloma lesions (<xref ref-type="bibr" rid="bib60">Via et al., 2008</xref>). The impact of hypoxia on mycobacteria under various ecological circumstances implies that the genes required for pathogenesis of MAC-PD may be, to some degree, overlapped with the genes with increased requirements in the clinical MAC-PD strains compared to ATCC13950, and also with the genes required for hypoxic pellicle formation in ATCC13950. To identify genes required for in vivo infection of clinical MAC-PD strains, we performed TnSeq in mice infected intratracheally with the Tn mutant library strains of M.i.198 or M.i.27, which we had demonstrated to be virulent in mice (<xref ref-type="fig" rid="fig1">Figure 1b</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib55">Tateishi et al., 2023</xref>). It is impossible to perform TnSeq in mouse lungs infected with ATCC13950 because ATCC13950 is eliminated within 4 weeks of infection (<xref ref-type="bibr" rid="bib55">Tateishi et al., 2023</xref>). The time course of the changes in the bacterial burden showed a pattern similar to those of the wild-type strains M.i.198 and M.i.27, respectively, except that it was not possible to harvest sufficient colonies (as few as 10<sup>4</sup> /mouse) in the few mice infected with the M.i.27 Tn mutant strain in Week 8 and Week 16 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1b</xref>, <xref ref-type="supplementary-material" rid="supp9">Supplementary file 9</xref>). With a resampling analysis, 629 and 512 genes were shown to be required for in vivo infection with transposon mutant library strains M.i.27 and M.i.198, respectively, at least at one time point between Day 1 and Week 16 of infection (<xref ref-type="fig" rid="fig6">Figure 6a</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1c and d</xref>, <xref ref-type="supplementary-material" rid="supp10 supp11">Supplementary files 10 and 11</xref>). Of these genes, 72 (11.9%) and 50 (9.76%) in M.i.27 and M.i.198, respectively, were also required for hypoxic pellicle formation in ATCC13950. Forty-one genes also required for hypoxic pellicle formation in ATCC13950 were identified in both M.i.27 and M.i.198 and included genes associated with succinate production (multifunctional 2-oxoglutarate metabolism enzyme) and the glyoxylate cycle (isocitrate lyase), cysteine and methionine synthesis (thiosulfate sulfurtransferase [CysA], 5-methyltetrahydrofolate-homocysteine methyltransferase [MetH]), the serine/threonine-protein kinase PknG system, proteasome subunits (PrcA, PrcB), DNA repair UvrC, secretion protein EspR, cell-wall synthesis proteins (such as phosphatidylinositol [polyprenol-phosphate-mannose-dependent alpha-[1-2]-phosphatidylinositol pentamannoside mannosyltransferase], peptidoglycan (penicillin-binding protein A pbpA), and <sc>l,d</sc>-transpeptidase 2), putative membrane proteins and transporters (such as the MmpL family, transport accessory protein MmpS3, transport protein MmpL11, vitamin B<sub>12</sub> transport ATP-binding protein BacA, ABC transporter substrate-binding protein, and ABC transporter permease), and mammalian cell entry (Mce) proteins (OCU_RS48855–48875) (<xref ref-type="supplementary-material" rid="supp12">Supplementary file 12</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Detection of genes required for mouse lung infection in the clinical <italic>M</italic>. <italic>intracellulare</italic> strains.</title><p>(<bold>a</bold>) Consistency between the genes required for infection in mouse lungs and the 175 genes required for hypoxic pellicle formation in ATCC13950. (<bold>b</bold>) Changes in the requirements for genes with increased genetic requirements observed in the clinical <italic>M. intracellulare</italic> strains after the infection of mouse lungs. Highlighted genes are also required for hypoxic pellicle formation by ATCC13950. Genetic requirements of the strain itself: genetic requirements compared with that of ATCC13950. Genetic requirements in mouse lungs: changes in the genetic requirements in the infected mouse lungs compared with those before infection. Gene set enrichment analysis: The genes listed as core enrichment are shown as ‘Yes’ and the genes not listed as core enrichment are shown as ‘No’.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Mouse infection experiment for transposon sequencing (TnSeq).</title><p>Mouse infection experiment for Transposon sequencing (TnSeq) (<bold>a</bold>) Schematic representation of mouse infection experiment. #Three mice were excluded from TnSeq because the number of harvested colonies was &lt;1×10<sup>4</sup> /mouse. § Three samples of M.i.198Tn at week 12 were grouped into M.i.198Tn at week 16 to represent the chronic phase of infection. $ Three mice were excluded from TnSeq because the number of harvested colonies was only 10<sup>3</sup>–10<sup>4</sup> /mouse. (<bold>b</bold>) Time-course changes in colony-forming units (CFUs) in mouse lungs after infection with M.i.198Tn or M.i.27Tn. Data on CFUs are from one biological experiment (N=1). Each dot represents an individual mouse. (<bold>c</bold>) Resampling assay to detect significantly reduced Tn insertion reads in infected mouse lungs compared with before infection. The data on time-course changes in CFUs in mouse lungs after infection with wild-type strains of M.i.198 or M.i.27 were published previously (<xref ref-type="bibr" rid="bib55">Tateishi et al., 2023</xref>). (<bold>d</bold>) Number of genes showing significantly reduced transposon (Tn) insertion reads in the infected mouse lungs compared with before infection according to a resampling analysis. As described above, the samples of M.i.198Tn in week 16 were derived from two mice killed in week 16 and one mouse killed in week 12.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Summary of the gene set enrichment analysis (GSEA) results.</title><p>The dataset of fitness costs for infection in mouse lungs in transposon (Tn) mutant libraries of M.i.27 and M.i.198 from day 1 to week 16 of infection was statistically tested to be enriched with the gene sets required for hypoxic pellicle formation observed in ATCC13950 and with those showing increased genetic requirements observed in the <italic>Mycobacterium avium–intracellulare</italic> complex pulmonary disease (MAC-PD) clinical strains. (Top) Statistics data for the gene set enrichment analysis. (Bottom) Data of enrichment plots. On the X-axis, the left direction indicates positive correlation with the conditions after infection in mouse lungs, and the right direction indicates positive correlation with the conditions outside of mouse lungs (i.e. negative correlation with the conditions after infection in mouse lungs). The ranking of the genes in the gene sets required for hypoxic pellicle formation observed in ATCC13950 and those showing increased genetic requirements observed in the MAC-PD clinical strains is shown in <xref ref-type="supplementary-material" rid="supp12">Supplementary file 12</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Summary of the gene set enrichment analysis (GSEA) results.</title><p>The dataset of fitness costs for infection in mouse lungs in transposon (Tn) mutant libraries of M.i.27 and M.i.198 was statistically tested to be enriched with the gene sets required for hypoxic pellicle formation observed in ATCC13950. (Top) Statistics data for the gene set enrichment analysis. (Bottom) Data of enrichment plots. On the X-axis, the left direction indicates positive correlation with the conditions after infection in mouse lungs, and the right direction indicates positive correlation with the conditions outside of mouse lungs (i.e. negative correlation with the conditions after infection in mouse lungs). The ranking of the genes in the gene sets required for hypoxic pellicle formation observed in ATCC13950 is shown in <xref ref-type="supplementary-material" rid="supp16">Supplementary file 16</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig6-figsupp3-v1.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>Summary of the gene set enrichment analysis (GSEA) results.</title><p>The dataset of fitness costs for infection in mouse lungs in transposon (Tn) mutant libraries of M.i.27 and M.i.198 was statistically tested to be enriched with those showing increased genetic requirements observed in the <italic>Mycobacterium avium–intracellulare</italic> complex pulmonary disease (MAC-PD) clinical strains. (Top) Statistics data for the gene set enrichment analysis. (Bottom) Data of enrichment plots. On the X-axis, the left direction indicates positive correlation with the conditions after infection in mouse lungs, and the right direction indicates positive correlation with the conditions outside of mouse lungs (i.e. negative correlation with the conditions after infection in mouse lungs). The ranking of the genes showing increased genetic requirements observed in the MAC-PD clinical strains is shown in <xref ref-type="supplementary-material" rid="supp17">Supplementary file 17</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig6-figsupp4-v1.tif"/></fig></fig-group><p>At all timepoints from Day1 to Week 16, there were 74 and 99 genes were shown to be required for lung infection with M.i.27 and M.i.198, respectively. Of them, 21 (28.3%) and 12 (12.1%) genes belonged to the genes involved in hypoxic pellicle formation in the type strain. At timepoints throughout Week 4 to Week 16, except for Day 1, there were 121 and 172 genes were shown to be required for lung infection with M.i.27 and M.i.198, respectively. Of them, 21 (23.1%) and 30 (18.0%) genes belonged to genes involved in hypoxic pellicle formation in the type strain. These hypoxic pellicle-associated genes detected both in M.i.27 and M.i.198 encoded methionine synthesis (MetH), acyl-CoA dehydrogenase, isocitrate lyase, MMPL family transporter (MmpL11) (from Day 1 to Week 16), additionally multifunctional oxoglutarate decarboxylase/dehydrogenase, proteasome subunits (PrcA, PrcB), ABC transporter ATP-binding protein/permease, lipase chaperone (from Week 4 to Week 16) (new <xref ref-type="supplementary-material" rid="supp13 supp14">Supplementary files 13 and 14</xref>).</p><p>The genes only identified in M.i.27 that were also required for hypoxic pellicle formation in ATCC13950 included genes associated with gluconeogenesis (<italic>pckA</italic>, <italic>glpX</italic>), the glycine cleavage system (<italic>gcvT</italic>), the type VII secretion system (<italic>eccD5, espG5, eccC5</italic> [OCU_RS38280-OCU_RS38285-OCU_RS38345], <italic>eccC3</italic> [OCU_RS48145]), and <sc>d</sc>-inositol 3-phosphate glycosyltransferase (<xref ref-type="supplementary-material" rid="supp12">Supplementary file 12</xref>). These three systems, gluconeogenesis, the glycine cleavage system, and the type VII secretion system, also showed increased genetic requirements in 3–5 clinical MAC-PD strains than in ATCC13950 (<xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig6">6</xref>). Although M.i.27 was excluded as a relevant strain showing increased genetic requirements of these three metabolic systems, the increase in genetic requirements for infection in vivo suggests a positive relationship between hypoxic growth in vitro and bacterial growth in vivo. In contrast, M.i.198 already showed increased genetic requirements in these three metabolic systems under aerobic conditions in vitro, so the genes associated with these three systems were not identified as having fewer Tn insertion reads during infection in vivo. Genes only identified in M.i.198 and required for hypoxic pellicle formation in ATCC13950 included genes associated with succinate synthesis (2-oxoglutarate oxidoreductase subunit KorA) or encoding the HTH-type transcriptional repressor KstR and menaquinone reductase (<xref ref-type="supplementary-material" rid="supp12">Supplementary file 12</xref>). As increased genetic requirements in 3–5 clinical strains (excluding M.i.198) compared with ATCC13950, an increased requirement for the RNA methyltransferase OCU_RS41540 was identified in M.i.198 during infection in vivo. These in vivo TnSeq data suggest that, despite the differences in the profiles of the genes required for in vivo infection between strains, an increase in genetic requirements for hypoxic growth in part contributes to the pathogenesis in vivo.</p><p>We have performed a statistical enrichment analysis of gene sets by GSEA <xref ref-type="bibr" rid="bib51">Subramanian et al., 2005</xref> to investigate whether the genes required for growth of M.i.27 and M.i.198 in mouse lungs overlap the gene sets required for hypoxic pellicle formation in ATCC13950, as well as the gene sets showing increased genetic requirements observed in the clinical MAC-PD strains listed in <xref ref-type="fig" rid="fig3">Figure 3</xref>. Of these gene sets, including a total of 180 genes, 54% (98 genes), and 40% (73 genes) were listed as enriched in genes required for mouse infection in M.i.27 and M.i.198, respectively (<italic>p</italic>&lt;0.01 in M.i.27 and <italic>p</italic>=0.016 in M.i.198) (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>, <xref ref-type="supplementary-material" rid="supp15">Supplementary file 15</xref>). The enriched genes both in M.i.27 and M.i.198 included genes encoding fructose–1,6-bisphosphatase (<italic>glpX</italic>), a type VII secretion protein (<italic>eccC5</italic>), glycine cleavage system aminomethyltransferase (<italic>gcvT</italic>), some phosphatase (OCU_RS30185), and a hypothetical protein (OCU_RS47290) (<xref ref-type="fig" rid="fig6">Figure 6</xref>). The enriched genes only in M.i.27 included genes of phosphoenolpyruvate carboxylinase (<italic>pckA</italic>), cysteine desulfurase (<italic>csd</italic>), and the ESX-5 type VII secretion component serine protease (<italic>mycP5</italic>). The enriched genes only in M.i.198 included genes encoding some phosphatase (OCU_RS35975) and class I SAM-dependent RNA methyltransferase (OCU_RS41540). Similarly, 40–50% of the genes required for ATCC13950’s hypoxic pellicle formation and strain-dependent/accessory essential genes are significantly enriched individually with the genes required for in vivo bacterial growth (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplements 3</xref> and <xref ref-type="fig" rid="fig6s4">4</xref>, <xref ref-type="supplementary-material" rid="supp16 supp17">Supplementary files 16 and 17</xref>). These data suggest the sharing of the hypoxia-adaptation pathways between in vitro hypoxic pellicle formation and in vivo bacterial growth.</p></sec><sec id="s2-6"><title>Effects of knockdown of universal essential or growth-defect-associated genes in clinical MAC-PD strains</title><p>To facilitate the functional analysis of the TnSeq-hit genes, it is necessary to construct the genetically engineered strains. Still now, there are very few reports of gene engineering of MAC strains and none of them has been accompanied by the follow-up studies (<xref ref-type="bibr" rid="bib25">Krzywinska et al., 2005</xref>; <xref ref-type="bibr" rid="bib20">Irani et al., 2004</xref>; <xref ref-type="bibr" rid="bib29">Marklund et al., 1995</xref>; <xref ref-type="bibr" rid="bib30">Marklund et al., 1998</xref>; <xref ref-type="bibr" rid="bib28">Mahenthiralingam et al., 1998</xref>; <xref ref-type="bibr" rid="bib19">Hinds et al., 1999</xref>). Moreover, no attempts have been reported to construct the knockdown strains in MAC strains. With an intention to evaluate the effect of suppressing TnSeq-hit genes on bacterial growth, we used the pRH2052/pRH2521 clustered regularly interspaced short palindromic repeats interference (CRISPR-i) plasmids to construct knockdown strains where the expression of the target gene is suppressed (<xref ref-type="bibr" rid="bib50">Singh et al., 2016</xref>; <xref ref-type="bibr" rid="bib8">Choudhary et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Rock et al., 2017</xref>). Of the nine <italic>M. intracellulare</italic> strains analyzed in this study, seven could be transformed with the vectors for single guide RNA (sgRNA) expression and dCas9 expression. However, the other two strains, M001 and MOTT64, could not be transformed with these CRISPR-i vectors. To confirm the gene essentiality detected with the HMM analysis, we evaluated the consequent growth inhibition in the knockdown strains of representative universal essential or growth-defect-associated genes, including <italic>glcB</italic>, <italic>inhA</italic>, <italic>gyrB</italic>, and <italic>embB</italic>. The knockdown strains showed growth suppression with comparative growth rates of knockdown strains to vector control strains that do not express single sgRNA reaching 10<sup>–1</sup> to 10<sup>–4</sup> (<xref ref-type="fig" rid="fig7">Figure 7a</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Evaluation of the effect of the suppression of Transposon sequencing (TnSeq)-hit genes on the bacterial growth using the CRISPR-i system.</title><p>Open bar: day 3; closed bar: day 7. (<bold>a</bold>) Comparative growth rates of the knockdown strains relative to those of the vector control strains in the representative universal essential or growth-defect-associated genes: <italic>glcB, inhA</italic>, <italic>gyrB,</italic> and <italic>embB</italic>. (<bold>b</bold>) Comparative growth rates of the knockdown strains relative to those of the vector control strains in the representative accessory and strain-dependent essential or growth-defect-associated genes: <italic>pckA</italic>, <italic>glpX</italic>, <italic>csd,</italic> and ESX-5 type VII secretion components. Data are shown as the means ± SD of triplicate experiments. Data from one experiment representative of two independent experiments (N=2) are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Comparative growth rates of the knockdown strains relative to those of the vector control strains in several accessory and strain-dependent essential or growth-defect-associated genes.</title><p>Data are shown as the means ± SD of triplicate experiments. Data from one experiment representative of two independent experiments (N=2) are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig7-figsupp1-v1.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Quantitative reverse transcription PCR (qRT-PCR) validation of the suppression of gene expression in knockdown strains of universal and strain-dependent/ accessory essential or growth-defect-associated genes.</title><p>(<bold>a</bold>) List of target universal essential or growth-defect-associated genes analyzed with qRT-PCR. (<bold>b</bold>) Levels of gene expression of the target universal essential or growth-defect-associated genes in knockdown strains compared with those in control strains not expressing guide RNA. (<bold>c</bold>) List of target strain-dependent/ accessory essential or growth-defect-associated genes analyzed with qRT-PCR. (<bold>d</bold>) Levels of gene expression of the target strain-dependent/ accessory essential or growth-defect-associated genes in knockdown strains compared with those in control strains not expressing guide RNA. Aliquots (10 mL) of log-phase bacterial cultures were prepared and the expression of guide RNA was induced by the addition of aTc on day 0 and day 2 (final concentrations of 50 ng/ml for ATCC13950 and M.i.27; 200 ng/ml for M.i.198, M018, M019, M003, and M021). The bacteria were harvested, RNA extracted, and qRT-PCR performed to evaluate the gene expression levels. Gene expression data are the means ± SD of triplicate experiments. Data from one experiment representative of two independent experiments (N=2) are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig7-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-7"><title>Differential effects of knockdown of accessory/strain-dependent essential or growth-defect-associated genes among clinical MAC-PD strains</title><p>As representative accessory and strain-dependent essential or growth-defect-associated genes, we evaluated the nine genes showing reduced Tn insertion reads in the 3–5 clinical MAC-PD strains as listed in <xref ref-type="fig" rid="fig3">Figure 3</xref>, as well as <italic>glpX</italic>, a gene of gluconeogenesis where four MAC-PD strains showed reduced Tn insertion reads in a resampling analysis (<xref ref-type="fig" rid="fig5">Figure 5b</xref>). The growth was suppressed in the <italic>pckA</italic>-knockdown strains in M.i.198 and M003, in the <italic>glpX</italic>-knockdown strain in M003, and in the cysteine desulfurase gene (<italic>csd</italic>)-knockdown strains in M.i.198 and M003, with comparative growth rates of knockdown strains to vector control strains reaching 10<sup>–2</sup> to 10<sup>–4</sup> (<xref ref-type="fig" rid="fig7">Figure 7b</xref>). The growth tended to be suppressed in the type VII secretion protein gene (<italic>eccC5</italic>)-knockdown strain in M003 and in the type VII secretion-associated serine protease mycosin gene (<italic>mycP5</italic>)-knockdown strain in M003, with comparative growth rates of knockdown strains to vector control strains reaching less than 10<sup>–1</sup>. By contrast, the growth was not suppressed in these knockdown strains in ATCC13950, with comparative growth rates of knockdown strains to vector control strains not reaching 10<sup>–1</sup>, which was consistent with the inessentiality of these genes under aerobic conditions in ATCC13950. As for M.i.198 and M003, the consistency between TnSeq data and CRISPR-i data was supported by a correlation between the growth suppression of the knockdown strains and the fitness costs evaluated by a resampling analysis (<xref ref-type="supplementary-material" rid="supp18">Supplementary file 18</xref>).</p><p>In contrast to the cases of M.i.198 and M003, the growth of knockdown strains of the accessory and strain-dependent essential genes was not effectively suppressed in the other MAC-PD strains despite being positively detected in TnSeq (<xref ref-type="fig" rid="fig7">Figure 7b</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). Although the gene expression levels were not suppressed to &lt;1% as reported in <italic>M. tuberculosis</italic> (Mtb) (<xref ref-type="bibr" rid="bib33">McNeil and Cook, 2019</xref>), the suppression of gene expression was confirmed to approximately 20–70% in the knockdown strains of these accessory and strain-dependent essential or growth-defect-associated genes, as well as universal essential or growth-defect-associated genes, such as <italic>glcB</italic>, <italic>inhA</italic>, <italic>gyrB</italic>, and <italic>embB</italic> (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). The possible reason may be explained by the recently revealed bypass mechanism of gene essentiality in strain-dependent/accessory essential or growth-defect-associated genes, where gene essentiality can be bypassed by several mechanisms, including the composition of the accessory genome and pathway rewiring (<xref ref-type="bibr" rid="bib45">Rosconi et al., 2022</xref>).</p><p>To be summarized, we could validate the universal essential or growth-defect-associated genes by the CRISPR-i system in the <italic>M. intracellulare</italic> strains used in this study. And, although not successful with all strains, we could validate the accessory and strain-dependent essential or growth-defect-associated genes, especially genes of gluconeogenesis, type VII secretion components, and iron-sulfur cluster assembly in several MAC-PD strains like M.i.198 and M003.</p></sec><sec id="s2-8"><title>Preferential hypoxic adaptation of clinical MAC-PD strains evaluated with bacterial growth kinetics</title><p>The metabolic remodeling, such as the increased genetic requirements of gluconeogenesis and the type VII secretion system, and the overlap of the genes required for mouse lung infection and those required for hypoxic pellicle formation involved by these metabolic pathways suggest the preferential adaptation of the clinical MAC-PD strains to hypoxic conditions. To confirm this, we investigated the growth kinetics of each strain under aerobic and hypoxic conditions. In terms of growth kinetics, most of the clinical MAC-PD strains (except M001) entered logarithmic (log) phase earlier than ATCC13950 under 5% oxygen (<xref ref-type="fig" rid="fig8">Figure 8a and b</xref>, <xref ref-type="supplementary-material" rid="supp19">Supplementary file 19</xref>). However, under aerobic conditions, the clinical MAC-PD strains entered log phase at a similar time to ATCC13950. The growth rate at the mid-log point (midpoint) was significantly reduced under hypoxic conditions in a total of five clinical MAC-PD strains (M.i.198, M.i.27, M003, M019, and M021) compared to aerobic conditions (<xref ref-type="fig" rid="fig8">Figure 8a and b</xref>, <xref ref-type="supplementary-material" rid="supp19">Supplementary file 19</xref>). The growth rate at midpoint under hypoxic conditions was significantly lower in these five clinical MAC-PD strains than in ATCC13950. The early entry to the log phase, followed by long-term logarithmic growth (slow growth rate at midpoint), suggests the capacity for these five clinical MAC-PD strains to continue replication for a long time under hypoxic conditions. On the other hand, the remaining three clinical MAC-PD strains (M018, M001, and MOTT64) did not show significant change in the growth rate between aerobic and hypoxic conditions, suggesting that there are different levels of capacity in maintaining long-term replication under hypoxia among clinical MAC-PD strains. In ATCC13950, the entry to log phase was significantly delayed under 5% oxygen compared to aerobic conditions, and the growth rate at midpoint was significantly increased under hypoxic conditions compared to aerobic conditions in ATCC13950. Such a long-term lag phase followed by short-term log phase suggests lower capacity for ATCC13950 to continue replication under hypoxic conditions compared to clinical MAC-PD strains.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Comparison of the timing of entry into logarithmic growth and logarithmic growth rate by the clinical <italic>M</italic>. <italic>intracellulare</italic> strains and ATCC13950.</title><p>(<bold>a</bold>) Representative data on the growth curves of each strain under aerobic and 5% oxygen conditions. The assay was performed three times in 96-well plates containing 250 μl of broth medium per well, in triplicate. Data are represented as colony-forming units (CFUs) in 4 μl samples at each timepoint. Data on the growth curves are the means of three biological replicates from one experiment. Data from one experiment representative of three independent experiments (N=3) are shown. (<bold>b</bold>) Time at the inflection point (midpoint) on the sigmoid growth curve. * Significantly earlier than an aerobic culture of ATCC13950; # Significantly earlier than a hypoxic culture of ATCC13950; † Significantly later than an aerobic culture of ATCC13950; ‡ Significantly later than a hypoxic culture of ATCC13950. (<bold>c</bold>) Growth rate at midpoint of the growth curve in each strain. # Significantly slower than a hypoxic culture of ATCC13950; †Significantly slower than an aerobic culture of the corresponding strain; ‡Significantly faster than an aerobic culture of ATCC13950. Open bars: aerobic; closed bars: 5% O<sub>2</sub>. Data are shown as the means ± SD of triplicate experiments. Data from one experiment representative of three independent experiments (N=3) are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig8-v1.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Data on the growth curve in ATCC13950 and its neighbor clinical <italic>M</italic>. <italic>intracellulare</italic> strains M005 and M016.</title><p>(<bold>a</bold>) Representative data on the growth curves of ATCC13950, M005, and M016 under aerobic and 5% oxygen conditions. The assay was performed three times in 96-well plates containing 250 μl of broth medium per well, in triplicate. Data are represented as colony-forming units (CFUs) in 4 μl samples at each timepoint. Data from one experiment representative of three independent experiments (N=3) are shown. (<bold>b</bold>) Comparison of the time at the inflection point (midpoint) on the sigmoid growth curve between the clinical <italic>M. intracellulare</italic> strains M005 and M016 and the type strain ATCC13950; <sup>#</sup> Significantly earlier than a hypoxic culture of ATCC13950; <sup>†</sup> Significantly later than an aerobic culture of ATCC13950; <sup>‡</sup> Significantly later than a hypoxic culture of ATCC13950. (<bold>c</bold>) Comparison of the logarithmic growth rate at midpoint between the clinical <italic>M. intracellulare</italic> strains M005 and M016 and the type strain ATCC13950. Open bars: aerobic; closed bars: 5% O<sub>2</sub>. Data are shown as the means ± SD of triplicate experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99426-fig8-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-9"><title>The pattern of hypoxic adaptation is not simply determined by genotypes</title><p>Since ATCC13950 and M018 are phylogenetically neighbors within the same TMI group each other, there may be a claim that the growth phenotypes of a longer lag phase compared to other strains under hypoxic conditions might be determined simply by the genotypes. To examine this, we performed hypoxic growth assays for an additional two strains (M005, M016) phylogenetically more closely related to ATCC13950 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). The result showed different growth patterns under hypoxia; M005 reached midpoint later than ATCC13950, by contrast M016 reached midpoint three-quarters earlier than ATCC13950 (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). These data suggest that genotypes seem to have some impact on bacterial growth pattern under hypoxia; however, since there was a significant difference in the timing of hypoxic adaptation among ATCC13950 and its neighbor strains, bacterial growth pattern under hypoxia seems to be determined by multiple factors other than genotypes, such as strain-specific profiles of genetic requirements and unproven regulatory systems.</p><p>In summary, the data on more rapid adaptation to hypoxia followed by reduced growth rate once adapted indicate the greater metabolic advantage on continuous logarithmic bacterial growth under hypoxic conditions in the clinical MAC-PD strains than in ATCC13950. Because the profiles of genetic requirements reflect the adaptation to the environment in which bacteria habits, it is reasonable to assume that the increase of genetic requirements in hypoxia-related genes, such as gluconeogenesis (<italic>pckA, glpX</italic>), type VII secretion system (<italic>mycP5, eccC5</italic>), and cysteine desulfurase (<italic>csd</italic>) plays an important role in the growth under hypoxia-relevant conditions in vivo.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, using TnSeq of nine genetically diverse <italic>M. intracellulare</italic> strains, we have identified 131 shared essential and growth-defect-associated genes with an HMM analysis. The genes identified are promising drug targets, representing the genomic diversity of the clinical MAC-PD strains and reflecting the actual clinical situation. The strategy of narrowing the essential genes of bacteria is a useful approach for refining the database of drug targets. We have also demonstrated an overview of the differences in genetic requirements for hypoxic growth between the ATCC type strain and the clinical <italic>M. intracellulare</italic> strains responsible for MAC-PD, with the evidence of earlier entry to log phase followed by slower growth rate observed in most of these clinical strains compared to ATCC13950. This is the first study to demonstrate the positive relationship between the profiles of increased genetic requirements for hypoxic metabolic remodeling and the phenotypes advantageous for bacterial survival under hypoxic conditions.</p><p>In this study, 121 genes were detected as significantly reduced Tn insertion in the clinical MAC-PD strains compared to ATCC13950, which was higher than the case of Mtb showing 10–50 genes with altered Tn insertion reads detected by a resampling analysis (<xref ref-type="bibr" rid="bib6">Carey et al., 2018</xref>). This may reflect the genomic diversity of <italic>M. intracellulare</italic> compared with that of Mtb. The proportion of accessory genes is larger in NTM than in Mtb (<xref ref-type="bibr" rid="bib63">Yang et al., 2018</xref>). In a clinical trial of phage therapy for <italic>M. abscessus</italic> infection, the number of accessory genes was shown to decrease with the loss of virulence in <italic>M. abscessus</italic> during the course of therapy (<xref ref-type="bibr" rid="bib38">Nick et al., 2022</xref>), suggesting some role for accessory genes in its clinical pathogenesis. Our data on the overlap of the accessory essential or growth-defect-associated genes, such as <italic>pckA</italic> and <italic>mycP5</italic> (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>) with genes required for mouse lung infection (<xref ref-type="fig" rid="fig6">Figure 6b</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>) supports the idea that accessory genes (non-core genes) may encode functions required for bacterial survival, especially under non-optimal conditions, such as hypoxia and during the infection of human and animal bodies.</p><p>Our TnSeq data are consistent with metabolomic data that have shown the importance of the gluconeogenic carbon flow of TCA cycle intermediates for bacterial growth under hypoxic conditions in terms of the essentiality of PckA and the reverse TCA cycle (<xref ref-type="bibr" rid="bib17">Eoh et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Lim et al., 2021</xref>; <xref ref-type="bibr" rid="bib31">Marrero et al., 2010</xref>; <xref ref-type="bibr" rid="bib61">Watanabe et al., 2011</xref>). Gluconeogenesis is essential for bacterial growth when fatty acids are used as a major nutrient (<xref ref-type="bibr" rid="bib31">Marrero et al., 2010</xref>). PckA catalyzes the conversion of the metabolites derived from the TCA cycle to the metabolites of gluconeogenesis (<xref ref-type="bibr" rid="bib27">Lim et al., 2021</xref>). The reaction catalyzed by PckA is essential for bacterial growth when the available nutrients are predominantly fatty acids (<xref ref-type="bibr" rid="bib18">Gouzy et al., 2021</xref>; <xref ref-type="bibr" rid="bib42">Quinonez et al., 2022</xref>). The main nutrients for mycobacteria inside hypoxic granulomas in an infected human or mouse body are lipids, such as fatty acids and cholesterol, rather than carbohydrates (<xref ref-type="bibr" rid="bib31">Marrero et al., 2010</xref>; <xref ref-type="bibr" rid="bib39">Pandey and Sassetti, 2008</xref>). In the present study, <italic>M. intracellulare</italic> grew under 5% oxygen, whereas Mtb stops growing under 1% oxygen and enters a dormant state (<xref ref-type="bibr" rid="bib27">Lim et al., 2021</xref>). The depletion of phosphoenolpyruvate in the <italic>pckA</italic> deletion mutant of Mtb reduced the phosphoenolpyruvate–carbon flux essential for bacterial growth and drug sensitivity (<xref ref-type="bibr" rid="bib27">Lim et al., 2021</xref>). The present study supports the idea that PckA is essential for the microaerobic growth of mycobacteria. Our TnSeq data imply the preferential adaptation of the clinical MAC-PD strains for circumstances in vivo, which are characterized by hypoxia.</p><p>On the other hand, such metabolic shift towards gluconeogenesis and reverse TCA cycle can also be observed under reactive nitrogen species and in vivo infection as well. This suggests that the metabolic shift observed under hypoxia is a general stress response rather than being specific to hypoxia due to the nature of the provided/available carbon source (<xref ref-type="bibr" rid="bib40">Prosser et al., 2017</xref>). Several factors other than hypoxia can be estimated to be related to the change of the genetic requirements in the clinical MAC-PD strains, such as host-related factors and general stress conditions (i.e. nutrition of abundant fatty acids and less carbohydrates, low pH circumstances) (<xref ref-type="bibr" rid="bib31">Marrero et al., 2010</xref>; <xref ref-type="bibr" rid="bib18">Gouzy et al., 2021</xref>; <xref ref-type="bibr" rid="bib42">Quinonez et al., 2022</xref>; <xref ref-type="bibr" rid="bib39">Pandey and Sassetti, 2008</xref>). Except for our data of the profile of genes required for hypoxic pellicle formation in <italic>M. intracellulare</italic> (<xref ref-type="bibr" rid="bib53">Tateishi et al., 2020</xref>), no fundamental genome-wide data are available on the change of the genetic requirements in response to each stress factor in non-tuberculous mycobacteria. Further studies are needed to discriminate which factors are specifically involved in the increased requirements of each gene. Although of interest, it is beyond the scope of the current study.</p><p>As in the <italic>glpX</italic>-knockdown strains, <italic>csd</italic> knockdown caused growth suppression in several MAC-PD strains. This type II Csd is involved in the biosynthesis of the iron–sulfur clusters of the SUF machinery. Compared with the type I cysteine desulfurase IscS, the SUF machinery is active under oxidative-stress and iron-limiting conditions (<xref ref-type="bibr" rid="bib52">Takahashi and Tokumoto, 2002</xref>). Representatives of iron–sulfur cluster proteins include components of the electron-transport system, such as NADH dehydrogenase I (Nuo) and succinate dehydrogenase (Sdh), which are components of respiratory complexes I and II, respectively. Under hypoxic conditions, the non-proton-translocating type II NADH dehydrogenase Ndh is upregulated, and cytochrome <italic>bd</italic> oxidase (CydAB) and the proton-pumping type I NADH dehydrogenase (Nuo) are downregulated (<xref ref-type="bibr" rid="bib40">Prosser et al., 2017</xref>). In the reverse TCA cycle on the same reaction pathway as Sdh, fumarate reductase (Fnr) is also an iron–sulfur cluster protein that produces succinate and is a proposed alternative electron acceptor under hypoxic conditions (<xref ref-type="bibr" rid="bib61">Watanabe et al., 2011</xref>; <xref ref-type="bibr" rid="bib7">Cecchini et al., 2002</xref>). The increased essentiality of the <italic>csd</italic> gene observed in the clinical MAC-PD strains seems to reflect the switching of the electron-transport system to less-energy-efficient respiration to support preferential hypoxic survival, including in vivo.</p><p>About 10% of the genes required for mouse infection are also required for hypoxic pellicle formation. The genes showing increased genetic requirements in the clinical MAC-PD strains, such as <italic>pckA</italic> and genes encoding the ESX-5 type VII secretion system, including <italic>eccC5</italic> and <italic>mycP5</italic>, also showed increased genetic requirements in mouse infections. In a TnSeq study of mice infected intravenously with <italic>M. avium</italic>, the genes of the ESX-5 type VII secretion system were required for infection of the liver and spleen (<xref ref-type="bibr" rid="bib15">Dragset et al., 2019</xref>). The ESX-5 type VII secretion system is involved in the transport of fatty acids and the virulence of mycobacteria (<xref ref-type="bibr" rid="bib3">Ates et al., 2015</xref>; <xref ref-type="bibr" rid="bib4">Ates et al., 2016</xref>). These similarities in the profiles of genetic requirements prompt us to propose some role of biofilm formation in mycobacterial pathogenesis in animals and humans. In the present study, we shed light on the impact of hypoxia on biofilm formation, the acquisition of virulence, and the in vivo pathogenesis of NTM in terms of global genetic requirements. Although the morphologies of the pellicle and macroscopic lesions (including cavitation and nodular bronchiectasis) are not similar, monitoring the expression of the genes identified in this study may provide clues to the mechanism of biofilm formation in vivo.</p><p>The data on the validation of the universal essential or growth-defect associated genes by the CRISPR-i system was overall acceptable in the clinically MAC-PD strains whose knockdown strains could be constructed (<xref ref-type="fig" rid="fig7">Figure 7a</xref>). However, we have encountered the difficulties of validating the TnSeq-hit genes by CRISPR-i experiment, especially accessory and strain-dependent essential or growth-defect-associated genes in the MAC-PD strains other than M.i.198 or M003 (<xref ref-type="fig" rid="fig7">Figure 7b</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). We found the lower efficiency of the suppression of gene expression by CRISPR-i in <italic>M. intracellulare</italic> than in Mtb that is reported to be suppressed to 6% under 10 ng/ml anhydrotetracycline (aTc) and by &lt;1% under 100 ng/ml aTc in the knockdown strains, compared to strains expressing scrambled single guide RNAs (sgRNA) (<xref ref-type="bibr" rid="bib33">McNeil and Cook, 2019</xref>). However, because the levels of knockdown efficiency were comparable between strain-dependent/accessory essential genes and universally essential genes (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>), the low efficiency of knockdown does not seem to explain the reason for the discrepancy between TnSeq and CRISPR-i results. Although it is difficult to find the clear definitive reason for this phenomenon only from the current study, the possible reason may be speculated by the bypass mechanism of gene essentiality which is characteristically observed in strain-dependent/accessory essential or growth-defect-associated genes. According to the publication by <xref ref-type="bibr" rid="bib45">Rosconi et al., 2022</xref> reporting the ‘forced-evolution experiments’ of 36 clinical <italic>Streptococcus pneumoniae</italic> strains, gene essentiality can be bypassed by several mechanisms, including the composition of the accessory genome and pathway rewiring. They successfully recovered knockout mutants from transformation experiments in strain-dependent/accessory essential genes, such as cytidine monophosphate kinase, a folate pathway enzyme formate tetrahydrofolate ligase and an undecaprenyl phosphate-biosynthesis pathway enzyme farnesyl-diphosphate synthase. The bypassing of gene essentiality could be suggested by observing suppressor mutations and synthetic lethality in knockout strains. By contrast, universal essential genes were reported to fulfill the three categories, including high levels of conservation within and often across species, limited genetic diversity, and high and stable expression levels. Consequently, universal essential genes were estimated to be rigid, largely immutable key components to an organism’s survival. The knockout recovery of the universal essential genes was reported to fail, as shown by no colonies or only the appearance of merodiploids. Taking into consideration such bypass mechanism of gene essentiality, the inconsistent effect of gene silencing of strain-dependent/accessory essential genes on bacterial growth may reflect some kinds of pathway rewiring that helps the bacteria grow under suppression of the target gene expression. Nevertheless, our study has opened the avenue for functional analysis of NTM that leads to the development of novel drugs targeting universal and accessory/strain-dependent essential metabolic pathways, especially by making use of M.i.198 and M003 as optimal NTM strains for gene manipulation.</p><p>In this study, we revealed the pattern of hypoxic adaptation characteristic to the clinical MAC-PD strains by the growth curve analysis: an early entry to log phase followed by a reduced growth rate (<xref ref-type="fig" rid="fig8">Figure 8</xref>). This pattern implicates the continuous impact on the infected hosts during logarithmic bacterial growth, which may be involved in the persistent and steadily progressive illness for years in humans (<xref ref-type="bibr" rid="bib12">Daley et al., 2020</xref>). The advantage of slow growth in mycobacteria may be inferred by the role of a histone-like nucleoid protein, mycobacterial DNA-binding protein 1 (MDP1), also designated HupB (<xref ref-type="bibr" rid="bib47">Savitskaya et al., 2018</xref>; <xref ref-type="bibr" rid="bib16">Enany et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Shaban et al., 2023</xref>). The expression of MDP1 is enhanced in the stationary phase, resulting in reduced growth speed and long-term survival with increased resistance to reactive oxygen species (ROS) (<xref ref-type="bibr" rid="bib47">Savitskaya et al., 2018</xref>; <xref ref-type="bibr" rid="bib16">Enany et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Shaban et al., 2023</xref>). The reduced growth rate after entry to the log phase may allow long-term survival of mycobacteria under ROS-rich circumstances inside host cells. The pattern of hypoxic adaptation as observed in the clinical MAC-PD strains may enhance pathogenesis by extending the period of the repeated process of bacterial invasion and replication in infected macrophages.</p><p>Contrary to our expectation, not all clinical strains showed rapid adaptation from aerobic to hypoxic conditions relative to ATCC13950. The two strains belonging to the MP-MIP subgroup, MOTT64 and M001, showed similar time at midpoint under aerobic conditions. However, the time at midpoint was significantly different between MOTT64 and M001 under hypoxia, the latter showing great delay of timing of entry to logarithmic phase. In contrast to the majority of the clinical strains that showed slow growth at midpoint under hypoxia, neither strain showed such a phenomenon. These data suggest that some, but not a major proportion of, clinical <italic>M. intracellulare</italic> strains do not have an advantageous phenotype for continuous logarithmic growth under hypoxia. In Mtb, the adaptation to hypoxia is considered to be necessary for clinical pathogenesis because the conditions in vivo, such as inside macrophages or granulomas, are hypoxic (<xref ref-type="bibr" rid="bib40">Prosser et al., 2017</xref>; <xref ref-type="bibr" rid="bib46">Rustad et al., 2009</xref>). Our inability to construct knockdown strains in M001 and MOTT64 prevented us from clarifying the factors that discriminate against the pattern of hypoxic adaptation. Although the implication in clinical situations has not been proven, strains without slow growth under hypoxia may have different (possibly strain-specific) mechanisms of hypoxic adaptation corresponding to their growth phenotypes under hypoxia. Nevertheless, because we have shown that most of the <italic>M. intracellulare</italic> strains with different genotypes showed preferential adaptation to hypoxia in this study, our results largely reflect the clinical situation of the etiological agents of MAC-PD. A possible strategy for identifying factors that confer clinical pathogenesis will be to focus on the major clinical strains that show preferential hypoxic adaptation.</p><p>We tried to use inhibitors of phosphoenolpyruvate carboxykinase to confirm the increased essentiality of the <italic>pckA</italic> gene. However, we detected no positive effect because millimolar 3-mercaptopicolinic acid is required to show the effect of inhibition, even in eukaryotic cells, which have no cell wall (<xref ref-type="bibr" rid="bib5">Brearley et al., 2020</xref>). Moreover, 3-alkyl-1,8-dibenzylxanthine (<xref ref-type="bibr" rid="bib35">Montal et al., 2019</xref>) also only effectively inhibits PckA in eukaryotic cells. However, PckA has been proposed as a drug target for Mtb (<xref ref-type="bibr" rid="bib32">Mcleod et al., 2019</xref>), so our TnSeq data seem to be consistent with studies directed towards antimycobacterial drug discovery.</p><p>We found the difference in capacity of transformation between strains belonging to the same genomic <italic>M. paraintracellulare-M. indicus pranii</italic> (MP-MIP) subgroup. Although the direct mechanism determining the competency for foreign DNA has not been elucidated in <italic>M. intracellulare</italic> and other NTM species, several studies on general bacteria suggest the difficulties of introducing foreign DNA into clinical strains compared to the laboratory strains. As suggested in <italic>Staphylococcus aureus</italic> (<xref ref-type="bibr" rid="bib10">Corvaglia et al., 2010</xref>), some clinical strains develop elimination systems of foreign nucleic acids, such as a type III-like restriction endonuclease. As suggested in gram-negative bacteria (<xref ref-type="bibr" rid="bib41">Qin et al., 2022</xref>), there may be some difference in cell surface structures between strains, resulting in the necessity of polymyxin B nonapeptide targeting cell membrane for transforming clinical strains. The efficiency of eliminating foreign DNA may be attributed to various kinds of strain-specific factors, including restriction endonuclease, natural CRISPR-interference system, and cell wall structures rather than a simple genotype factor.</p><p>There may be a claim that the saturation of Tn insertion in most of each replicate were 50–60% in our libraries. However, our method of constructing Tn mutant libraries is in accordance with the previous studies of ‘high-density’ transposon libraries (<xref ref-type="bibr" rid="bib2">Akusobi et al., 2025</xref>) because the saturation of the Tn mutant libraries by combining replicates are 62–79% as follows: ATCC13950: 67.6%, M001: 72.9%, M003: 63.0%, M018: 62.4%, M019: 74.5%, M.i.27: 76.6%, M.i.198: 68.0%, MOTT64: 77.6%, M021: 79.9%. That is, we predicted gene essentiality from the Tn mutant libraries with 62–79% saturation in each strain. However, there is a non-permissive sequence pattern in mariner transposon mutagenesis and using more than 10 replicates of Tn mutant libraries is reported to be a more accurate method (<xref ref-type="bibr" rid="bib14">DeJesus et al., 2017</xref>; <xref ref-type="bibr" rid="bib43">Rifat et al., 2021</xref>). The issue of high probability of judging nonessential regions as mistakenly as ‘essential’ are mainly found in small ORFs (2–9 TA sites) rather than larger ORFs (TA sites &gt;= 10) (<xref ref-type="bibr" rid="bib14">DeJesus et al., 2017</xref>). There are 4136 (6.43% of total ORFs) nonpermissive TA sites in ATCC13950, which is less than in <italic>M. tuberculosis</italic> H37Rv (9% of total ORFs) <xref ref-type="bibr" rid="bib14">DeJesus et al., 2017</xref> and in <italic>M. abscessus</italic> ATCC19977 (8.1% of total ORFs) (<xref ref-type="bibr" rid="bib43">Rifat et al., 2021</xref>). As for small ORFs (2–9 TA sites), there are non-permissive TA sites in 41 genes (ORFs) of common essential or growth-defect-associated (1.35% of a total of 3021 larger ORFs in ATCC13950). With respect to the covering of non-permissive sites, our TnSeq data may need to be improved to classify quite accurately the gene essentiality, particularly on the nonstructural small regulatory genes, including small RNAs, although the study by DeJesus shows the comparable number of essential genes in large genes possessing more than 10 TA sites between 2 and 14 TnSeq datasets, most of which seem to be structural genes (<xref ref-type="bibr" rid="bib14">DeJesus et al., 2017</xref>).</p><p>We have provided the data suggesting the preferential hypoxic adaptation in clinical strains compared to the ATCC type strain by the growth assay of individual strains. To strengthen our claim, several experiments are suggested, including mixed culture experiments of clinical and reference strains under hypoxia. However, co-culture conditions introduce additional variables, including inter-strain competition or synergy, which can obscure the specific contributions of hypoxic adaptation in each strain. Therefore, we took the current approach using monoculture growth curves under defined oxygen conditions, which offers a clearer interpretation of strain-specific hypoxic responses. Furthermore, one of the limitations of this study is the lack of validation of TnSeq results with individual gene knockouts. Contrary to the case of Mtb, the technique of constructing knockout mutants of slow-growing NTM, including <italic>M. intracellulare</italic> has not been established for a long time. We have just recently succeeded in constructing the vector plasmids for making knockout mutants of <italic>M. intracellulare (</italic><xref ref-type="bibr" rid="bib56">Tateishi et al., 2024</xref>). A growth assay of individual knockout strains of genes showing increased genetic requirements, such as <italic>pckA</italic>, <italic>glpX</italic>, <italic>csd</italic>, <italic>eccC5,</italic> and <italic>mycP5</italic> in the clinical strains is suggested to provide the direct involvement of these genes on the preferential hypoxic adaptation in clinical strains. We have a future plan to construct knockout mutants of these genes to confirm the involvement of these genes in preferential hypoxic adaptation.</p><p>In summary, we have identified 131 universal essential and growth-defect-associated genes that cover the genomic diversity of <italic>M. intracellulare</italic> strains responsible for MAC-PD, which narrowed down the drug targets against MAC-PD. Furthermore, we have demonstrated preferential adaptation to hypoxia in clinical NTM strains compared with the type strain in terms of the increased genetic requirements for hypoxic growth, such as those encoding phosphoenolpyruvate carboxykinase, the ESX-5 type VII secretion system, and cysteine desulfurase. These genes were shown to have a significant impact on infection in vivo by increasing their genetic requirements. Our data highlight the importance of using clinical strains and hypoxic conditions in experimental research and provide fundamental resources for developing novel drugs directed towards nontuberculous mycobacterial strains that cause severe clinical diseases.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Bacterial strains and phages used to prepare Tn mutants</title><p>A total of eleven strains were used in this study, including nine clinical strains isolated from patients with MAC-PD in Japan (M.i.198, M.i.27, M018, M003, M019, M021, M001, M005, M016) (<xref ref-type="bibr" rid="bib55">Tateishi et al., 2023</xref>), <italic>M. intracellulare</italic> genovar <italic>paraintracellulare</italic> type strain MOTT64 isolated from MAC-PD in South Korea (<xref ref-type="bibr" rid="bib21">Kim et al., 2012</xref>) and the <italic>M. intracellulare</italic> type strain ATCC13950 (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). All eleven clinical strains from MAC-PD patients in Japan were isolated from sputum (<xref ref-type="bibr" rid="bib54">Tateishi et al., 2021</xref>; <xref ref-type="bibr" rid="bib55">Tateishi et al., 2023</xref>). Sputum samples were treated by the standard method for clinical isolation of mycobacteria with 0.5% (w/v) N-acetyl-L-cysteine and 2% (w/v) sodium hydroxide and plated on 7H10/OADC agar. Single colonies were picked up for use in experiments as isolated strains. Of these strains, ATCC13950, M.i.198, M.i.27, M018, M005, and M016 belong to the typical <italic>M. intracellulare</italic> (TMI) genotype and M001, M003, M019, M021, and MOTT64 belong to the <italic>M. paraintracellulare-M. indicus pranii</italic> (MP-MIP) genotype (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). The Tn mutant libraries were constructed using glucose as a carbon source under aerobic conditions according to the transduction method used for ATCC13950 (<xref ref-type="bibr" rid="bib53">Tateishi et al., 2020</xref>), except that a higher concentration of kanamycin (100 μg/ml) was used to select the transposon mutants than was used for ATCC13950 (25 μg/ml). In brief, a hundred milliliter of the bacteria were cultured aerobically in Middlebrook 7H9 medium (Difco Laboratories, Detroit, MI, USA) containing 0.2% glycerol, 0.1% Tween 80 (MP Biochemicals, Illkirch, France), and 10% Middlebrook albumin–dextrose–catalase (7H9/ADC/Tween 80) until mid-log phase (optical density at a wavelength of 600 nm [OD<sub>600</sub>] of approximately 0.4–0.6). After harvesting the bacteria, 10 mL of high-titer mycobacteriophage phAE180 (<xref ref-type="bibr" rid="bib23">Kriakov et al., 2003</xref>) was transduced into the bacteria for 1 day at 37 °C for inserting Tn and plated on Middlebrook 7H10 solid medium supplemented with 10% oleic acid-albumin-dextrose-catalase (Becton Dickinson and Co., Sparks, MD) (7H10/OADC) agar plates containing kanamycin. After 2 or 3 weeks of cultivation at 37 °C aerobically, the colonies were harvested <italic>en masse</italic> and used as Tn mutant libraries. The kanamycin-resistant colonies (&gt;1×10<sup>5</sup>) were harvested and evenly resuspended in 7H9/ADC medium containing 20% glycerol, aliquoted, and stored at −80 °C until further use.</p></sec><sec id="s4-2"><title>Next-generation sequencing and TnSeq analysis</title><p>DNA libraries were prepared as reported previously (<xref ref-type="bibr" rid="bib34">Minato et al., 2019</xref>). The TnSeq libraries were sequenced with the NextSeq 500 System, 150 bp single-end run (Illumina, San Diego, CA, USA). The sequence reads were analyzed as previously described (<xref ref-type="bibr" rid="bib53">Tateishi et al., 2020</xref>). Genetic requirements were calculated, and gene essentiality was predicted by resampling and HMM analyses using TRANSIT, respectively (<xref ref-type="bibr" rid="bib13">DeJesus et al., 2015</xref>). First, an HMM analysis was conducted to calculate the fluctuation of the number of Tn insertion reads individually for each strain. The HMM method can categorize the gene essentiality throughout the genome, including ‘Essential,’ ‘Growth-defect,’ ‘Non-essential,’and ‘Growth-advantage.’ ‘Essential’ genes are defined as no insertions in all or most of their TA sites. ‘Non-essential’ genes are defined as regions that have usual read counts. ‘Growth-defect’ genes are defined as regions that have unusually low read counts. ‘Growth-advantage’ genes are defined as regions that have unusually high low read counts. Universal essential and growth-defect-associated genes were identified as the genes classified as ‘Essential’ and ‘Growth-defect’ with an HMM analysis in all 9 subject strains (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Next, a resampling analysis was conducted to calculate the difference of the number of Tn insertion reads between each clinical strain and ATCC13950 (<xref ref-type="supplementary-material" rid="supp8">Supplementary file 8</xref>). By comparing the data obtained by HMM and resampling analyses, we summarized the difference in genetic requirements between the clinical MAC-PD strains and ATCC13950. To compare the genetic requirements of the clinical MAC-PD strains and ATCC13950, the annotation for the clinical MAC-PD strains was adapted from that of ATCC13950 by adjusting the START and END coordinates of each open reading frame (ORF) in the clinical MAC-PD strains according to their alignment with the corresponding ORFs of ATCC13950. The number of Tn insertions in our datasets varied between 1.3–5.8 million among strains. To reduce the variation in the Tn insertion across strains, we adopt a non-linear normalization method, Beta-Geometric correction (BGC). BGC normalizes the datasets to fit an ‘ideal’ geometric distribution with a variable probability parameter ρ (<xref ref-type="bibr" rid="bib13">DeJesus et al., 2015</xref>), and BGC improves resampling by reducing the skew. On the TRANSIT software, we set the replicate option as Sum to combine read counts. And we normalized the datasets by BGC and performed resampling analysis by using the normalized datasets to compare the genetic requirements between strains. The function of TnSeq-hit genes was categorized according to the Kyoto Encyclopedia of Genes and Genomes (KEGG) database.</p></sec><sec id="s4-3"><title>Animals</title><p>Female C57BL/6JJcl mice were purchased from CLEA Japan (Tokyo, Japan). Six-week-old mice were used for the infection experiment (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). All the mice were kept under specific-pathogen-free conditions in the animal facility of Niigata University Graduate School of Medicine, according to the institutional guidelines for animal experiments. The mice were housed (four per cage) under a 12 hr/12 hr light/dark cycle. Food and water were available ad libitum. Kanamycin was added to the drinking water to a final concentration of 100 μg/ml to maintain the mice’s resistance to the Tn mutant strains. Euthanasia was conducted with an intraperitoneal injection of a combined anesthetic (15 μg of medetomidine, 80 μg of midazolam, and 100 μg of butorphanol), followed by cervical dislocation.</p></sec><sec id="s4-4"><title>Mouse TnSeq experiment</title><p>The protocol was based on our previous mouse lung infection experiment (<xref ref-type="bibr" rid="bib55">Tateishi et al., 2023</xref>). Twenty mice each were used for the Tn mutant strains M.i.198 and M.i.27. The mice were injected intratracheally with 3.25×10<sup>8</sup> and 5.93×10<sup>7</sup> CFUs of the Tn mutant strains, respectively. The infected lungs were expected to be harvested from five mice at day 1, week 4, week 8, and week 16 after infection. However, the lungs were harvested from only four mice infected with the M.i.27 Tn mutant strains in week 8 because we experienced difficulties with sampling, and the lungs were harvested from only three, one, and two mice infected with M.i.198 Tn mutant strains in week 8, week 12, and week 16, respectively, because morbidity was high in the mice infected with M.i.198. The harvested lungs were homogenized in 4.5 ml of distilled water with the gentleMACS Tissue Dissociator (Miltenyi Biotec, Bergisch Gladbach, Germany) and the homogenates were plated on 7H10/OADC agar plates and cultured for 3 weeks. The colonies were harvested <italic>en masse</italic> for TnSeq.</p></sec><sec id="s4-5"><title>Gene set enrichment analysis</title><p>To investigate the overlap of the gene sets required for growth in mouse lungs with those required for hypoxic pellicle formation observed in ATCC13950 and those showing increased genetic requirements observed in the clinical MAC-PD strains, a statistical enrichment of gene sets was performed by GSEA 4.3.2 (<xref ref-type="bibr" rid="bib51">Subramanian et al., 2005</xref>). Parameters set for GSEA were as follows: permutations = 1000, permutation type: gene_set, enrichment statistic: weighted, metric for ranking genes: Signal2Noise, max size: 500, min size: 15.</p></sec><sec id="s4-6"><title>Construction and growth assay of knockdown strains</title><p>Knockdown strains were constructed with the CRISPR-dCas9-mediated RNA interference system, as reported previously (<xref ref-type="bibr" rid="bib50">Singh et al., 2016</xref>). Gene-specific 20-nt sequences were selected as protospacers for incorporation into the sgRNAs (<xref ref-type="supplementary-material" rid="supp20">Supplementary file 20</xref>). pRH2502 (a vector expressing an inactivated version of the <italic>cas9</italic> DNA sequence) and pRH2521 (an sgRNA-expressing vector whose expression is regulated by the TetR-regulated smyc promoter P<sub>myc1</sub>tetO) were introduced into the bacteria to obtain colonies of the knockdown strains. For selection, 25 μg/ml kanamycin and 50 μg/ml hygromycin were used for ATCC13950, and 100 μg/ml kanamycin and 50 μg/ml hygromycin were used for the clinical strains. The growth assay of the knockdown strains was performed in 7H9/ADC broth containing the above-mentioned concentrations of kanamycin and hygromycin under aerobic conditions at 37 °C with humidification (APM-30D incubator, Astec, Tokyo, Japan). During the assay, the cultures were supplemented with anhydrotetracycline (aTc) to a final concentration of 50 ng/ml (as a concentration that is not toxic to ATCC13950 and M.i.27) or 200 ng/ml (for the other clinical strains). aTc was added repeatedly every 48 hr to maintain the induction of dCas9 and sgRNAs in experiments that extended beyond 48 h (<xref ref-type="bibr" rid="bib50">Singh et al., 2016</xref>). An aliquot (4 μl) of the culture and its diluents were streaked onto 7H10/OADC agar plates containing kanamycin and hygromycin, and the CFUs were counted. Growth inhibition was evaluated as the ratio of the CFUs of knockdown strains compared with those of the vector control strains lacking the guide RNA sequence. To confirm the downregulation of gene expression in the knockdown strains, quantitative reverse transcription PCR (qRT-PCR) was performed. Bacteria were cultured in 10 ml of 7H9/ADC/Tween 80 containing kanamycin and hygromycin until mid-log phase (OD<sub>600</sub> approximately 0.4–0.6). The cultures were supplemented with aTc every 48 hr, as in the growth assay for the knockdown strains. One day after the second addition of aTc, RNA was extracted by bead-beating six times at 5000 rpm for 30 s with cooling (Micro Smash MS 100 R Cell Disruptor; Tomy Seiko, Tokyo, Japan) and cDNA was synthesized with the Direct-zol RNA Miniprep (Zymo Research, Orange, CA, USA) and ReverTra Ace qPCR RT Master Mix with gDNA Remover (Toyobo, Osaka, Japan). qRT-PCR was performed with the CFX Connect Real-time PCR Detection System (Bio-Rad, Hercules, CA, USA), according to the manufacturer’s instructions. The data were normalized to the expression of <italic>sigA</italic>.</p></sec><sec id="s4-7"><title>Comparison of growth curves under aerobic and hypoxic conditions</title><p>First, we precultured the bacteria in 7H9/ADC broth until the bacteria reached early log phase (OD<sub>600</sub> approximately 0.1–0.3). Next, the bacterial cultures were diluted with new 7H9/ADC broth (final OD<sub>600</sub> 0.003) for the aerobic and hypoxic growth assay. Bacterial cells were grown statically in 96-well plates containing 250 μl of 7H9/ADC broth in each well under aerobic conditions or 5% oxygen at 37 °C with humidification (APM-30D incubator, Astec, Tokyo, Japan). The culture was sampled every 1–3 days. At sampling, the culture was mixed by pipetting 50 times. An aliquot (4 μl) of the culture and its diluents were streaked onto 7H10/OADC agar and the CFUs counted. The growth curve was fitted to the logistic 4 P model with the JMP software (SAS Institute Inc, Cary, NC, USA) to calculate the inflection point (midpoint) and growth rate at midpoint in the log growth phase. Entry into the log phase was evaluated from the timing of the inflection point on the growth curve.</p></sec><sec id="s4-8"><title>Statistical analyses</title><p>The cut-off of fold change (log<sub>2</sub>FC) to compare genetic requirements by TnSeq resampling analysis was set as adjusted <italic>p</italic>-values less than 0.05. Pearson’s correlation test was performed between the fitness costs (log<sub>2</sub>FC calculated by the resampling assay), efficiency of knockdown (assessed by qRT-PCR) and growth suppression in the knockdown strains. Statistical analyses of the growth curves were performed using a 4-parameter logistic model (logistic 4 P model), Wilcoxon two-sample test, and a one-way analysis of variance (ANOVA) followed by Steel’s multiple comparisons test using the JMP software program (SAS Institute Inc, Cary, NC, USA). Data are presented as the mean ± SD. Statistical significance was set as <italic>p</italic> values less than 0.05.</p></sec><sec id="s4-9"><title>Consent for publication</title><p>According to the protocols approved by the Institutional Review Board of Niigata University mentioned above, consent for publication was obtained from the patients enrolled in this study.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Resources</p></fn><fn fn-type="con" id="con3"><p>Resources</p></fn><fn fn-type="con" id="con4"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: All experimental protocols were approved by the Institutional Review Board of Niigata University (approval numbers: 2019-0020 for the use of human tissue samples). All experiments on humans and human samples were conducted in accordance with relevant guidelines and regulations. Informed consent was obtained from all patients.</p></fn><fn fn-type="other"><p>All experimental protocols were approved by the Institutional Review Board of Niigata University (SA00506 for experiments on live vertebrates). All experiments on animals were conducted in accordance with the relevant guidelines and regulations, and the study complied with the ARRIVE guidelines.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Genotypes of study strains and the strains used for each experiment.</title></caption><media xlink:href="elife-99426-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Number of reads obtained and TA coverage in each replicate of transposon (Tn) mutant library strains.</title><p>Data for ATCC13950 are from our previous study (<xref ref-type="bibr" rid="bib53">Tateishi et al., 2020</xref>).</p></caption><media xlink:href="elife-99426-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Number of essential, growth-defect-associated, nonessential, and growth-advantage-associated genes detected with an hidden Markov model (HMM) analysis in each <italic>M. intracellulare</italic> strain.</title><p>Data for ATCC13950 are from our previous study (<xref ref-type="bibr" rid="bib53">Tateishi et al., 2020</xref>).</p></caption><media xlink:href="elife-99426-supp3-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>List of genes identified as universal essential or growth-defect-associated among the nine <italic>M. intracellulare</italic> strains analyzed in this study.</title><p>ES: essential, GD: growth-defect-associated.</p></caption><media xlink:href="elife-99426-supp4-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>List of genes identified as accessory essential or growth-defect-associated in the accessory genome and strain-dependent essential or growth-defect-associated in the core genes of <italic>M. intracellulare</italic>.</title><p>‘Hit’ represents the genes identified as essential or growth-defect-associated in each strain. The data of the pan-genome were referred to our previous study (<xref ref-type="bibr" rid="bib54">Tateishi et al., 2021</xref>).</p></caption><media xlink:href="elife-99426-supp5-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Result of the gene set enrichment analysis (GSEA) in strain-dependent/accessory essential or growth-defect-associated genes.</title><p>Genes required for hypoxic pellicle formation observed in ATCC13950 were ordered by their position in the ranked list of genes. Only 31 genes were ranked because the rest of the 144 genes were not present in the gene set of strain-dependent or accessory essential genes.</p></caption><media xlink:href="elife-99426-supp6-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>Classification of the genes showing increased genetic requirements in the clinical <italic>Mycobacterium avium–intracellulare</italic> complex pulmonary disease (MAC-PD) strains compared to ATCC13950, and the genes of gluconeogenesis, fructose-1,6-bisphosphatase <italic>glpX,</italic> with respect to the core and accessory genomes.</title></caption><media xlink:href="elife-99426-supp7-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp8"><label>Supplementary file 8.</label><caption><title>List of genes showing significantly increased or reduced transposon (Tn) insertion reads in the clinical <italic>M. intracellulare</italic> strains compared with ATCC13950 by a resampling analysis, with information of the genetic requirements detected by an hidden Markov model (HMM) analysis.</title></caption><media xlink:href="elife-99426-supp8-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp9"><label>Supplementary file 9.</label><caption><title>Number of transposon (Tn) insertion reads in samples from infected mouse lungs.</title><p>Individual mice are represented as A–E after the sampling time points.</p></caption><media xlink:href="elife-99426-supp9-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp10"><label>Supplementary file 10.</label><caption><title>List of genes identified with a resampling analysis in mouse lungs infected with M.i.198 transposon (Tn) mutant library strains.</title></caption><media xlink:href="elife-99426-supp10-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp11"><label>Supplementary file 11.</label><caption><title>List of genes identified with a resampling analysis in mouse lungs infected with M.i.27 transposon (Tn) mutant library strains.</title></caption><media xlink:href="elife-99426-supp11-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp12"><label>Supplementary file 12.</label><caption><title>List of genes required for mouse lung infection that are also required for hypoxic pellicle formation by ATCC13950.</title></caption><media xlink:href="elife-99426-supp12-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp13"><label>Supplementary file 13.</label><caption><title>List of genes required for mouse lung infection at all time points from Day 1 to Week 16, and from Week 4 to Week 16.</title></caption><media xlink:href="elife-99426-supp13-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp14"><label>Supplementary file 14.</label><caption><title>List of genes required for mouse lung infection at all time points from Day 1 to Week 16, and from Week 4 to Week 16, as well as required for hypoxic pellicle formation in ATCC13950.</title></caption><media xlink:href="elife-99426-supp14-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp15"><label>Supplementary file 15.</label><caption><title>Result of the gene set enrichment analysis (GSEA).</title><p>Genes in the gene sets required for hypoxic pellicle formation observed in ATCC13950 and those showing increased genetic requirements observed in the clinical <italic>Mycobacterium avium–intracellulare</italic> complex pulmonary disease (MAC-PD) strains were ordered by their position in the ranked list of genes.</p></caption><media xlink:href="elife-99426-supp15-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp16"><label>Supplementary file 16.</label><caption><title>Result of the gene set enrichment analysis (GSEA) in mouse Transposon sequencing (TnSeq) datasets.</title><p>Genes required for hypoxic pellicle formation observed in ATCC13950 were ordered by their position in the ranked list of genes.</p></caption><media xlink:href="elife-99426-supp16-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp17"><label>Supplementary file 17.</label><caption><title>Result of the gene set enrichment analysis (GSEA) in mouse Transposon sequencing (TnSeq) datasets.</title><p>Genes showing increased genetic requirements observed in the clinical <italic>Mycobacterium avium–intracellulare</italic> complex pulmonary disease (MAC-PD) strains were ordered by their position in the ranked list of genes.</p></caption><media xlink:href="elife-99426-supp17-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp18"><label>Supplementary file 18.</label><caption><title>Correlation analysis between the fitness costs (log<sub>2</sub>FC), efficiency of knockdown (quantitative reverse transcription PCR, qRT-PCR) and growth suppression in the knockdown strains of strain-dependent/accessory essential or growth-defect-associated genes.</title></caption><media xlink:href="elife-99426-supp18-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp19"><label>Supplementary file 19.</label><caption><title>The raw data of colony-forming units (CFUs) used for drawing growth curves in <xref ref-type="fig" rid="fig8">Figure 8a</xref>.</title></caption><media xlink:href="elife-99426-supp19-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp20"><label>Supplementary file 20.</label><caption><title>Oligonucleotides and primers used in this study.</title></caption><media xlink:href="elife-99426-supp20-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-99426-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The TnSeq sequencing datasets are openly available in the DDBJ Sequence Read Archive database with the primary accession numbers DRA017301. The authors confirm that the data supporting the findings of this study other than the TnSeq sequencing datasets are available within the article.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Tateishi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Sequence read archives of M. intracellulare TnSeq in year 2023</data-title><source>DDBJ Sequence Read Archive</source><pub-id pub-id-type="accession" xlink:href="https://ddbj.nig.ac.jp/search/entry/sra-submission/DRA017301">DRA017301</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors thank Dr. Torin Weisbrod and Dr. William R Jacobs, Jr. (Albert Einstein College of Medicine, Bronx, NY, USA) for kindly providing mycobacterial phage phAE180, and Dr. Norikazu Hara and Dr. Takeshi Ikeuchi (Department of Molecular Genetics, Bioresource Science, Brain Center for Bioresources, Brain Research Institute, Niigata University) for next-generation sequencing with the NextSeq 500 System. The authors thank Mr. Naomi Yoshihara and Ms. Chisa Kumagai for constructing Tn mutant library strains and hypoxic growth experiments, respectively. This work was supported by Grants-in-Aid for Scientific Research (grant numbers 20KK0216, 21K19637, and 22H03115 to Yoshitaka Tateishi) from the Ministry of Health, Labour, and Welfare, of Japan. This work was also supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, the Ministry of Health, and the Research Program on Emerging Infectious Disease from the Japan Agency for Medical Research and Development (23fk0108673h0501, AMED-CREST 25gm1610009h0004, and JP223fa627005).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adjemian</surname><given-names>J</given-names></name><name><surname>Olivier</surname><given-names>KN</given-names></name><name><surname>Seitz</surname><given-names>AE</given-names></name><name><surname>Holland</surname><given-names>SM</given-names></name><name><surname>Prevots</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>185</volume><fpage>881</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1164/rccm.201111-2016OC</pub-id><pub-id pub-id-type="pmid">22312016</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akusobi</surname><given-names>C</given-names></name><name><surname>Choudhery</surname><given-names>S</given-names></name><name><surname>Benghomari</surname><given-names>BS</given-names></name><name><surname>Wolf</surname><given-names>ID</given-names></name><name><surname>Singhvi</surname><given-names>S</given-names></name><name><surname>Ioerger</surname><given-names>TR</given-names></name><name><surname>Rubin</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Transposon-sequencing across multiple <italic>Mycobacterium abscessus</italic> isolates reveals significant functional genomic diversity among strains</article-title><source>mBio</source><volume>16</volume><elocation-id>e0337624</elocation-id><pub-id pub-id-type="doi">10.1128/mbio.03376-24</pub-id><pub-id pub-id-type="pmid">39745363</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ates</surname><given-names>LS</given-names></name><name><surname>Ummels</surname><given-names>R</given-names></name><name><surname>Commandeur</surname><given-names>S</given-names></name><name><surname>van de Weerd</surname><given-names>R</given-names></name><name><surname>Sparrius</surname><given-names>M</given-names></name><name><surname>Weerdenburg</surname><given-names>E</given-names></name><name><surname>Alber</surname><given-names>M</given-names></name><name><surname>Kalscheuer</surname><given-names>R</given-names></name><name><surname>Piersma</surname><given-names>SR</given-names></name><name><surname>Abdallah</surname><given-names>AM</given-names></name><name><surname>Abd El Ghany</surname><given-names>M</given-names></name><name><surname>Abdel-Haleem</surname><given-names>AM</given-names></name><name><surname>Pain</surname><given-names>A</given-names></name><name><surname>Jiménez</surname><given-names>CR</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name><name><surname>Houben</surname><given-names>ENG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Essential role of the ESX-5 secretion system in outer membrane permeability of pathogenic mycobacteria</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1005190</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005190</pub-id><pub-id pub-id-type="pmid">25938982</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ates</surname><given-names>LS</given-names></name><name><surname>van der Woude</surname><given-names>AD</given-names></name><name><surname>Bestebroer</surname><given-names>J</given-names></name><name><surname>van Stempvoort</surname><given-names>G</given-names></name><name><surname>Musters</surname><given-names>RJP</given-names></name><name><surname>Garcia-Vallejo</surname><given-names>JJ</given-names></name><name><surname>Picavet</surname><given-names>DI</given-names></name><name><surname>van de Weerd</surname><given-names>R</given-names></name><name><surname>Maletta</surname><given-names>M</given-names></name><name><surname>Kuijl</surname><given-names>CP</given-names></name><name><surname>van der Wel</surname><given-names>NN</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The ESX-5 system of pathogenic mycobacteria is involved in capsule integrity and virulence through its substrate PPE10</article-title><source>PLOS Pathogens</source><volume>12</volume><elocation-id>e1005696</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005696</pub-id><pub-id pub-id-type="pmid">27280885</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brearley</surname><given-names>MC</given-names></name><name><surname>Daniel</surname><given-names>ZCTR</given-names></name><name><surname>Loughna</surname><given-names>PT</given-names></name><name><surname>Parr</surname><given-names>T</given-names></name><name><surname>Brameld</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, 3-mercaptopicolinic acid (3-MPA), induces myogenic differentiation in C2C12 cells</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>22177</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-79324-9</pub-id><pub-id pub-id-type="pmid">33335245</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carey</surname><given-names>AF</given-names></name><name><surname>Rock</surname><given-names>JM</given-names></name><name><surname>Krieger</surname><given-names>IV</given-names></name><name><surname>Chase</surname><given-names>MR</given-names></name><name><surname>Fernandez-Suarez</surname><given-names>M</given-names></name><name><surname>Gagneux</surname><given-names>S</given-names></name><name><surname>Sacchettini</surname><given-names>JC</given-names></name><name><surname>Ioerger</surname><given-names>TR</given-names></name><name><surname>Fortune</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TnSeq of <italic>Mycobacterium tuberculosis</italic> clinical isolates reveals strain-specific antibiotic liabilities</article-title><source>PLOS Pathogens</source><volume>14</volume><elocation-id>e1006939</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006939</pub-id><pub-id pub-id-type="pmid">29505613</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cecchini</surname><given-names>G</given-names></name><name><surname>Schröder</surname><given-names>I</given-names></name><name><surname>Gunsalus</surname><given-names>RP</given-names></name><name><surname>Maklashina</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Succinate dehydrogenase and fumarate reductase from <italic>Escherichia coli</italic></article-title><source>Biochimica et Biophysica Acta</source><volume>1553</volume><fpage>140</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/s0005-2728(01)00238-9</pub-id><pub-id pub-id-type="pmid">11803023</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhary</surname><given-names>E</given-names></name><name><surname>Thakur</surname><given-names>P</given-names></name><name><surname>Pareek</surname><given-names>M</given-names></name><name><surname>Agarwal</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gene silencing by CRISPR interference in mycobacteria</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6267</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7267</pub-id><pub-id pub-id-type="pmid">25711368</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coll</surname><given-names>F</given-names></name><name><surname>Phelan</surname><given-names>J</given-names></name><name><surname>Hill-Cawthorne</surname><given-names>GA</given-names></name><name><surname>Nair</surname><given-names>MB</given-names></name><name><surname>Mallard</surname><given-names>K</given-names></name><name><surname>Ali</surname><given-names>S</given-names></name><name><surname>Abdallah</surname><given-names>AM</given-names></name><name><surname>Alghamdi</surname><given-names>S</given-names></name><name><surname>Alsomali</surname><given-names>M</given-names></name><name><surname>Ahmed</surname><given-names>AO</given-names></name><name><surname>Portelli</surname><given-names>S</given-names></name><name><surname>Oppong</surname><given-names>Y</given-names></name><name><surname>Alves</surname><given-names>A</given-names></name><name><surname>Bessa</surname><given-names>TB</given-names></name><name><surname>Campino</surname><given-names>S</given-names></name><name><surname>Caws</surname><given-names>M</given-names></name><name><surname>Chatterjee</surname><given-names>A</given-names></name><name><surname>Crampin</surname><given-names>AC</given-names></name><name><surname>Dheda</surname><given-names>K</given-names></name><name><surname>Furnham</surname><given-names>N</given-names></name><name><surname>Glynn</surname><given-names>JR</given-names></name><name><surname>Grandjean</surname><given-names>L</given-names></name><name><surname>Minh Ha</surname><given-names>D</given-names></name><name><surname>Hasan</surname><given-names>R</given-names></name><name><surname>Hasan</surname><given-names>Z</given-names></name><name><surname>Hibberd</surname><given-names>ML</given-names></name><name><surname>Joloba</surname><given-names>M</given-names></name><name><surname>Jones-López</surname><given-names>EC</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Miranda</surname><given-names>A</given-names></name><name><surname>Moore</surname><given-names>DJ</given-names></name><name><surname>Mocillo</surname><given-names>N</given-names></name><name><surname>Panaiotov</surname><given-names>S</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Penha</surname><given-names>C</given-names></name><name><surname>Perdigão</surname><given-names>J</given-names></name><name><surname>Portugal</surname><given-names>I</given-names></name><name><surname>Rchiad</surname><given-names>Z</given-names></name><name><surname>Robledo</surname><given-names>J</given-names></name><name><surname>Sheen</surname><given-names>P</given-names></name><name><surname>Shesha</surname><given-names>NT</given-names></name><name><surname>Sirgel</surname><given-names>FA</given-names></name><name><surname>Sola</surname><given-names>C</given-names></name><name><surname>Oliveira Sousa</surname><given-names>E</given-names></name><name><surname>Streicher</surname><given-names>EM</given-names></name><name><surname>Helden</surname><given-names>PV</given-names></name><name><surname>Viveiros</surname><given-names>M</given-names></name><name><surname>Warren</surname><given-names>RM</given-names></name><name><surname>McNerney</surname><given-names>R</given-names></name><name><surname>Pain</surname><given-names>A</given-names></name><name><surname>Clark</surname><given-names>TG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genome-wide analysis of multi- and extensively drug-resistant <italic>Mycobacterium tuberculosis</italic></article-title><source>Nature Genetics</source><volume>50</volume><fpage>307</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1038/s41588-017-0029-0</pub-id><pub-id pub-id-type="pmid">29358649</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corvaglia</surname><given-names>AR</given-names></name><name><surname>François</surname><given-names>P</given-names></name><name><surname>Hernandez</surname><given-names>D</given-names></name><name><surname>Perron</surname><given-names>K</given-names></name><name><surname>Linder</surname><given-names>P</given-names></name><name><surname>Schrenzel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A type III-like restriction endonuclease functions as a major barrier to horizontal gene transfer in clinical <italic>Staphylococcus aureus</italic> strains</article-title><source>PNAS</source><volume>107</volume><fpage>11954</fpage><lpage>11958</lpage><pub-id pub-id-type="doi">10.1073/pnas.1000489107</pub-id><pub-id pub-id-type="pmid">20547849</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuttino</surname><given-names>JT</given-names></name><name><surname>McCABE</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="1949">1949</year><article-title>Pure granulomatous nocardiosis, a new fungus disease distinguished by intracellular parasitism; a description of a new disease in man due to a hitherto undescribed organism, Nocardia intracellularis, n. sp., including a study of the biologic and pathogenic properties of this species</article-title><source>The American Journal of Pathology</source><volume>25</volume><fpage>1</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">18106962</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daley</surname><given-names>CL</given-names></name><name><surname>Iaccarino</surname><given-names>JM</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name><name><surname>Cambau</surname><given-names>E</given-names></name><name><surname>Wallace</surname><given-names>RJ</given-names></name><name><surname>Andrejak</surname><given-names>C</given-names></name><name><surname>Böttger</surname><given-names>EC</given-names></name><name><surname>Brozek</surname><given-names>J</given-names></name><name><surname>Griffith</surname><given-names>DE</given-names></name><name><surname>Guglielmetti</surname><given-names>L</given-names></name><name><surname>Huitt</surname><given-names>GA</given-names></name><name><surname>Knight</surname><given-names>SL</given-names></name><name><surname>Leitman</surname><given-names>P</given-names></name><name><surname>Marras</surname><given-names>TK</given-names></name><name><surname>Olivier</surname><given-names>KN</given-names></name><name><surname>Santin</surname><given-names>M</given-names></name><name><surname>Stout</surname><given-names>JE</given-names></name><name><surname>Tortoli</surname><given-names>E</given-names></name><name><surname>van Ingen</surname><given-names>J</given-names></name><name><surname>Wagner</surname><given-names>D</given-names></name><name><surname>Winthrop</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline</article-title><source>The European Respiratory Journal</source><volume>56</volume><elocation-id>2000535</elocation-id><pub-id pub-id-type="doi">10.1183/13993003.00535-2020</pub-id><pub-id pub-id-type="pmid">32636299</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeJesus</surname><given-names>MA</given-names></name><name><surname>Ambadipudi</surname><given-names>C</given-names></name><name><surname>Baker</surname><given-names>R</given-names></name><name><surname>Sassetti</surname><given-names>C</given-names></name><name><surname>Ioerger</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TRANSIT--a software tool for Himar1 TnSeq analysis</article-title><source>PLOS Computational Biology</source><volume>11</volume><elocation-id>e1004401</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004401</pub-id><pub-id pub-id-type="pmid">26447887</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeJesus</surname><given-names>MA</given-names></name><name><surname>Gerrick</surname><given-names>ER</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Park</surname><given-names>SW</given-names></name><name><surname>Long</surname><given-names>JE</given-names></name><name><surname>Boutte</surname><given-names>CC</given-names></name><name><surname>Rubin</surname><given-names>EJ</given-names></name><name><surname>Schnappinger</surname><given-names>D</given-names></name><name><surname>Ehrt</surname><given-names>S</given-names></name><name><surname>Fortune</surname><given-names>SM</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name><name><surname>Ioerger</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Comprehensive essentiality analysis of the <italic>Mycobacterium tuberculosis</italic> genome via saturating transposon mutagenesis</article-title><source>mBio</source><volume>8</volume><elocation-id>e02133-16</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02133-16</pub-id><pub-id pub-id-type="pmid">28096490</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragset</surname><given-names>MS</given-names></name><name><surname>Ioerger</surname><given-names>TR</given-names></name><name><surname>Loevenich</surname><given-names>M</given-names></name><name><surname>Haug</surname><given-names>M</given-names></name><name><surname>Sivakumar</surname><given-names>N</given-names></name><name><surname>Marstad</surname><given-names>A</given-names></name><name><surname>Cardona</surname><given-names>PJ</given-names></name><name><surname>Klinkenberg</surname><given-names>G</given-names></name><name><surname>Rubin</surname><given-names>EJ</given-names></name><name><surname>Steigedal</surname><given-names>M</given-names></name><name><surname>Flo</surname><given-names>TH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Global assessment of Mycobacterium avium subsp. <italic>hominissuis</italic> genetic requirement for growth and virulence</article-title><source>mSystems</source><volume>4</volume><elocation-id>e00402-19</elocation-id><pub-id pub-id-type="doi">10.1128/mSystems.00402-19</pub-id><pub-id pub-id-type="pmid">31822597</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enany</surname><given-names>S</given-names></name><name><surname>Yoshida</surname><given-names>Y</given-names></name><name><surname>Tateishi</surname><given-names>Y</given-names></name><name><surname>Ozeki</surname><given-names>Y</given-names></name><name><surname>Nishiyama</surname><given-names>A</given-names></name><name><surname>Savitskaya</surname><given-names>A</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Ohara</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Ato</surname><given-names>M</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mycobacterial DNA-binding protein 1 is critical for long term survival of <italic>Mycobacterium smegmatis</italic> and simultaneously coordinates cellular functions</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>6810</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-06480-w</pub-id><pub-id pub-id-type="pmid">28754952</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eoh</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Layre</surname><given-names>E</given-names></name><name><surname>Rath</surname><given-names>P</given-names></name><name><surname>Morris</surname><given-names>R</given-names></name><name><surname>Branch Moody</surname><given-names>D</given-names></name><name><surname>Rhee</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Metabolic anticipation in <italic>Mycobacterium tuberculosis</italic></article-title><source>Nature Microbiology</source><volume>2</volume><elocation-id>17084</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2017.84</pub-id><pub-id pub-id-type="pmid">28530656</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouzy</surname><given-names>A</given-names></name><name><surname>Healy</surname><given-names>C</given-names></name><name><surname>Black</surname><given-names>KA</given-names></name><name><surname>Rhee</surname><given-names>KY</given-names></name><name><surname>Ehrt</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Growth of <italic>Mycobacterium tuberculosis</italic> at acidic pH depends on lipid assimilation and is accompanied by reduced GAPDH activity</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2024571118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2024571118</pub-id><pub-id pub-id-type="pmid">34341117</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinds</surname><given-names>J</given-names></name><name><surname>Mahenthiralingam</surname><given-names>E</given-names></name><name><surname>Kempsell</surname><given-names>KE</given-names></name><name><surname>Duncan</surname><given-names>K</given-names></name><name><surname>Stokes</surname><given-names>RW</given-names></name><name><surname>Parish</surname><given-names>T</given-names></name><name><surname>Stoker</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Enhanced gene replacement in mycobacteria</article-title><source>Microbiology</source><volume>145 ( Pt 3)</volume><fpage>519</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1099/13500872-145-3-519</pub-id><pub-id pub-id-type="pmid">10217485</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irani</surname><given-names>VR</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Eckstein</surname><given-names>TM</given-names></name><name><surname>Inamine</surname><given-names>JM</given-names></name><name><surname>Belisle</surname><given-names>JT</given-names></name><name><surname>Maslow</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Utilization of a ts-sacB selection system for the generation of a Mycobacterium avium serovar-8 specific glycopeptidolipid allelic exchange mutant</article-title><source>Annals of Clinical Microbiology and Antimicrobials</source><volume>3</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1186/1476-0711-3-18</pub-id><pub-id pub-id-type="pmid">15458565</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>BJ</given-names></name><name><surname>Choi</surname><given-names>BS</given-names></name><name><surname>Lim</surname><given-names>JS</given-names></name><name><surname>Choi</surname><given-names>IY</given-names></name><name><surname>Kook</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Complete genome sequence of Mycobacterium intracellulare clinical strain MOTT-64, belonging to the INT1 genotype</article-title><source>Journal of Bacteriology</source><volume>194</volume><elocation-id>3268</elocation-id><pub-id pub-id-type="doi">10.1128/JB.00471-12</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirschner</surname><given-names>RA</given-names></name><name><surname>Parker</surname><given-names>BC</given-names></name><name><surname>Falkinham</surname><given-names>JO</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Epidemiology of infection by nontuberculous mycobacteria. Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum in acid, brown-water swamps of the southeastern United States and their association with environmental variables</article-title><source>The American Review of Respiratory Disease</source><volume>145</volume><fpage>271</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1164/ajrccm/145.2_Pt_1.271</pub-id><pub-id pub-id-type="pmid">1736730</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kriakov</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Jacobs</surname><given-names>WR</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Identification of a regulated alkaline phosphatase, a cell surface-associated lipoprotein, in <italic>Mycobacterium smegmatis</italic></article-title><source>Journal of Bacteriology</source><volume>185</volume><fpage>4983</fpage><lpage>4991</lpage><pub-id pub-id-type="doi">10.1128/JB.185.16.4983-4991.2003</pub-id><pub-id pub-id-type="pmid">12897018</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krieger</surname><given-names>IV</given-names></name><name><surname>Freundlich</surname><given-names>JS</given-names></name><name><surname>Gawandi</surname><given-names>VB</given-names></name><name><surname>Roberts</surname><given-names>JP</given-names></name><name><surname>Gawandi</surname><given-names>VB</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Owen</surname><given-names>JL</given-names></name><name><surname>Fraile</surname><given-names>MT</given-names></name><name><surname>Huss</surname><given-names>SI</given-names></name><name><surname>Lavandera</surname><given-names>J-L</given-names></name><name><surname>Ioerger</surname><given-names>TR</given-names></name><name><surname>Sacchettini</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Structure-guided discovery of phenyl-diketo acids as potent inhibitors of <italic>M. tuberculosis</italic> malate synthase</article-title><source>Chemistry &amp; Biology</source><volume>19</volume><fpage>1556</fpage><lpage>1567</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2012.09.018</pub-id><pub-id pub-id-type="pmid">23261599</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krzywinska</surname><given-names>E</given-names></name><name><surname>Bhatnagar</surname><given-names>S</given-names></name><name><surname>Sweet</surname><given-names>L</given-names></name><name><surname>Chatterjee</surname><given-names>D</given-names></name><name><surname>Schorey</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mycobacterium avium 104 deleted of the methyltransferase D gene by allelic replacement lacks serotype-specific glycopeptidolipids and shows attenuated virulence in mice</article-title><source>Molecular Microbiology</source><volume>56</volume><fpage>1262</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04608.x</pub-id><pub-id pub-id-type="pmid">15882419</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Poulton</surname><given-names>NC</given-names></name><name><surname>Chang</surname><given-names>JS</given-names></name><name><surname>Azadian</surname><given-names>ZA</given-names></name><name><surname>DeJesus</surname><given-names>MA</given-names></name><name><surname>Ruecker</surname><given-names>N</given-names></name><name><surname>Zimmerman</surname><given-names>MD</given-names></name><name><surname>Eckartt</surname><given-names>KA</given-names></name><name><surname>Bosch</surname><given-names>B</given-names></name><name><surname>Engelhart</surname><given-names>CA</given-names></name><name><surname>Sullivan</surname><given-names>DF</given-names></name><name><surname>Gengenbacher</surname><given-names>M</given-names></name><name><surname>Dartois</surname><given-names>VA</given-names></name><name><surname>Schnappinger</surname><given-names>D</given-names></name><name><surname>Rock</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in <italic>Mycobacterium tuberculosis</italic></article-title><source>Nature Microbiology</source><volume>7</volume><fpage>766</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1038/s41564-022-01130-y</pub-id><pub-id pub-id-type="pmid">35637331</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Lee</surname><given-names>S-K</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Eum</surname><given-names>S-Y</given-names></name><name><surname>Eoh</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Phosphoenolpyruvate depletion mediates both growth arrest and drug tolerance of <italic>Mycobacterium tuberculosis</italic> in hypoxia</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2105800118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2105800118</pub-id><pub-id pub-id-type="pmid">34426499</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahenthiralingam</surname><given-names>E</given-names></name><name><surname>Marklund</surname><given-names>BI</given-names></name><name><surname>Brooks</surname><given-names>LA</given-names></name><name><surname>Smith</surname><given-names>DA</given-names></name><name><surname>Bancroft</surname><given-names>GJ</given-names></name><name><surname>Stokes</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Site-directed mutagenesis of the 19-kilodalton lipoprotein antigen reveals No essential role for the protein in the growth and virulence of Mycobacterium intracellulare</article-title><source>Infection and Immunity</source><volume>66</volume><fpage>3626</fpage><lpage>3634</lpage><pub-id pub-id-type="doi">10.1128/IAI.66.8.3626-3634.1998</pub-id><pub-id pub-id-type="pmid">9673242</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marklund</surname><given-names>BI</given-names></name><name><surname>Speert</surname><given-names>DP</given-names></name><name><surname>Stokes</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Gene replacement through homologous recombination in Mycobacterium intracellulare</article-title><source>Journal of Bacteriology</source><volume>177</volume><fpage>6100</fpage><lpage>6105</lpage><pub-id pub-id-type="doi">10.1128/jb.177.21.6100-6105.1995</pub-id><pub-id pub-id-type="pmid">7592373</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marklund</surname><given-names>BI</given-names></name><name><surname>Mahenthiralingam</surname><given-names>E</given-names></name><name><surname>Stokes</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Site-directed mutagenesis and virulence assessment of the katG gene of Mycobacterium intracellulare</article-title><source>Molecular Microbiology</source><volume>29</volume><fpage>999</fpage><lpage>1008</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.1998.00982.x</pub-id><pub-id pub-id-type="pmid">9767568</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marrero</surname><given-names>J</given-names></name><name><surname>Rhee</surname><given-names>KY</given-names></name><name><surname>Schnappinger</surname><given-names>D</given-names></name><name><surname>Pethe</surname><given-names>K</given-names></name><name><surname>Ehrt</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for <italic>Mycobacterium tuberculosis</italic> to establish and maintain infection</article-title><source>PNAS</source><volume>107</volume><fpage>9819</fpage><lpage>9824</lpage><pub-id pub-id-type="doi">10.1073/pnas.1000715107</pub-id><pub-id pub-id-type="pmid">20439709</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mcleod</surname><given-names>MJ</given-names></name><name><surname>Krismanich</surname><given-names>AP</given-names></name><name><surname>Assoud</surname><given-names>A</given-names></name><name><surname>Dmitrienko</surname><given-names>GI</given-names></name><name><surname>Holyoak</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Characterization of 3-[(Carboxymethyl)thio]picolinic Acid: a novel inhibitor of phosphoenolpyruvate carboxykinase</article-title><source>Biochemistry</source><volume>58</volume><fpage>3918</fpage><lpage>3926</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.9b00583</pub-id><pub-id pub-id-type="pmid">31461616</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNeil</surname><given-names>MB</given-names></name><name><surname>Cook</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Utilization of CRISPR interference to validate MmpL3 as a drug target in <italic>Mycobacterium tuberculosis</italic></article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>63</volume><elocation-id>e00629-19</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.00629-19</pub-id><pub-id pub-id-type="pmid">31160289</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minato</surname><given-names>Y</given-names></name><name><surname>Gohl</surname><given-names>DM</given-names></name><name><surname>Thiede</surname><given-names>JM</given-names></name><name><surname>Chacón</surname><given-names>JM</given-names></name><name><surname>Harcombe</surname><given-names>WR</given-names></name><name><surname>Maruyama</surname><given-names>F</given-names></name><name><surname>Baughn</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genomewide assessment of <italic>Mycobacterium tuberculosis</italic> conditionally essential metabolic pathways</article-title><source>mSystems</source><volume>4</volume><elocation-id>e00070-19</elocation-id><pub-id pub-id-type="doi">10.1128/mSystems.00070-19</pub-id><pub-id pub-id-type="pmid">31239393</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montal</surname><given-names>ED</given-names></name><name><surname>Bhalla</surname><given-names>K</given-names></name><name><surname>Dewi</surname><given-names>RE</given-names></name><name><surname>Ruiz</surname><given-names>CF</given-names></name><name><surname>Haley</surname><given-names>JA</given-names></name><name><surname>Ropell</surname><given-names>AE</given-names></name><name><surname>Gordon</surname><given-names>C</given-names></name><name><surname>Haley</surname><given-names>JD</given-names></name><name><surname>Girnun</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inhibition of phosphoenolpyruvate carboxykinase blocks lactate utilization and impairs tumor growth in colorectal cancer</article-title><source>Cancer &amp; Metabolism</source><volume>7</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.1186/s40170-019-0199-6</pub-id><pub-id pub-id-type="pmid">31388420</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namkoong</surname><given-names>H</given-names></name><name><surname>Kurashima</surname><given-names>A</given-names></name><name><surname>Morimoto</surname><given-names>K</given-names></name><name><surname>Hoshino</surname><given-names>Y</given-names></name><name><surname>Hasegawa</surname><given-names>N</given-names></name><name><surname>Ato</surname><given-names>M</given-names></name><name><surname>Mitarai</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan</article-title><source>Emerging Infectious Diseases</source><volume>22</volume><fpage>1116</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.3201/eid2206.151086</pub-id><pub-id pub-id-type="pmid">27191735</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>HT</given-names></name><name><surname>Wolff</surname><given-names>KA</given-names></name><name><surname>Cartabuke</surname><given-names>RH</given-names></name><name><surname>Ogwang</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A lipoprotein modulates activity of the MtrAB two-component system to provide intrinsic multidrug resistance, cytokinetic control and cell wall homeostasis in Mycobacterium</article-title><source>Molecular Microbiology</source><volume>76</volume><fpage>348</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07110.x</pub-id><pub-id pub-id-type="pmid">20233304</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nick</surname><given-names>JA</given-names></name><name><surname>Dedrick</surname><given-names>RM</given-names></name><name><surname>Gray</surname><given-names>AL</given-names></name><name><surname>Vladar</surname><given-names>EK</given-names></name><name><surname>Smith</surname><given-names>BE</given-names></name><name><surname>Freeman</surname><given-names>KG</given-names></name><name><surname>Malcolm</surname><given-names>KC</given-names></name><name><surname>Epperson</surname><given-names>LE</given-names></name><name><surname>Hasan</surname><given-names>NA</given-names></name><name><surname>Hendrix</surname><given-names>J</given-names></name><name><surname>Callahan</surname><given-names>K</given-names></name><name><surname>Walton</surname><given-names>K</given-names></name><name><surname>Vestal</surname><given-names>B</given-names></name><name><surname>Wheeler</surname><given-names>E</given-names></name><name><surname>Rysavy</surname><given-names>NM</given-names></name><name><surname>Poch</surname><given-names>K</given-names></name><name><surname>Caceres</surname><given-names>S</given-names></name><name><surname>Lovell</surname><given-names>VK</given-names></name><name><surname>Hisert</surname><given-names>KB</given-names></name><name><surname>de Moura</surname><given-names>VC</given-names></name><name><surname>Chatterjee</surname><given-names>D</given-names></name><name><surname>De</surname><given-names>P</given-names></name><name><surname>Weakly</surname><given-names>N</given-names></name><name><surname>Martiniano</surname><given-names>SL</given-names></name><name><surname>Lynch</surname><given-names>DA</given-names></name><name><surname>Daley</surname><given-names>CL</given-names></name><name><surname>Strong</surname><given-names>M</given-names></name><name><surname>Jia</surname><given-names>F</given-names></name><name><surname>Hatfull</surname><given-names>GF</given-names></name><name><surname>Davidson</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection</article-title><source>Cell</source><volume>185</volume><fpage>1860</fpage><lpage>1874</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.04.024</pub-id><pub-id pub-id-type="pmid">35568033</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>AK</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mycobacterial persistence requires the utilization of host cholesterol</article-title><source>PNAS</source><volume>105</volume><fpage>4376</fpage><lpage>4380</lpage><pub-id pub-id-type="doi">10.1073/pnas.0711159105</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prosser</surname><given-names>G</given-names></name><name><surname>Brandenburg</surname><given-names>J</given-names></name><name><surname>Reiling</surname><given-names>N</given-names></name><name><surname>Barry</surname><given-names>CE</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition</article-title><source>Microbes and Infection</source><volume>19</volume><fpage>177</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2016.10.001</pub-id><pub-id pub-id-type="pmid">27780773</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Pullela</surname><given-names>K</given-names></name><name><surname>Morona</surname><given-names>R</given-names></name><name><surname>Henderson</surname><given-names>IR</given-names></name><name><surname>Totsika</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A method for increasing electroporation competence of Gram-negative clinical isolates by polymyxin B nonapeptide</article-title><source>Scientific Reports</source><volume>12</volume><elocation-id>11629</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-022-15997-8</pub-id><pub-id pub-id-type="pmid">35804085</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinonez</surname><given-names>CG</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Lim</surname><given-names>J</given-names></name><name><surname>Odell</surname><given-names>M</given-names></name><name><surname>Lawson</surname><given-names>CP</given-names></name><name><surname>Anyogu</surname><given-names>A</given-names></name><name><surname>Raheem</surname><given-names>S</given-names></name><name><surname>Eoh</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The role of fatty acid metabolism in drug tolerance of <italic>Mycobacterium tuberculosis</italic></article-title><source>mBio</source><volume>13</volume><elocation-id>e0355921</elocation-id><pub-id pub-id-type="doi">10.1128/mbio.03559-21</pub-id><pub-id pub-id-type="pmid">35012349</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rifat</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Kreiswirth</surname><given-names>BN</given-names></name><name><surname>Nuermberger</surname><given-names>EL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Genome-Wide essentiality analysis of <italic>Mycobacterium abscessus</italic> by saturated transposon mutagenesis and deep sequencing</article-title><source>mBio</source><volume>12</volume><elocation-id>e0104921</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01049-21</pub-id><pub-id pub-id-type="pmid">34126767</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rock</surname><given-names>JM</given-names></name><name><surname>Hopkins</surname><given-names>FF</given-names></name><name><surname>Chavez</surname><given-names>A</given-names></name><name><surname>Diallo</surname><given-names>M</given-names></name><name><surname>Chase</surname><given-names>MR</given-names></name><name><surname>Gerrick</surname><given-names>ER</given-names></name><name><surname>Pritchard</surname><given-names>JR</given-names></name><name><surname>Church</surname><given-names>GM</given-names></name><name><surname>Rubin</surname><given-names>EJ</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name><name><surname>Schnappinger</surname><given-names>D</given-names></name><name><surname>Fortune</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform</article-title><source>Nature Microbiology</source><volume>2</volume><elocation-id>16274</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.274</pub-id><pub-id pub-id-type="pmid">28165460</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosconi</surname><given-names>F</given-names></name><name><surname>Rudmann</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Surujon</surname><given-names>D</given-names></name><name><surname>Anthony</surname><given-names>J</given-names></name><name><surname>Frank</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>DS</given-names></name><name><surname>Rock</surname><given-names>C</given-names></name><name><surname>Rosch</surname><given-names>JW</given-names></name><name><surname>Johnston</surname><given-names>CD</given-names></name><name><surname>van Opijnen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A bacterial pan-genome makes gene essentiality strain-dependent and evolvable</article-title><source>Nature Microbiology</source><volume>7</volume><fpage>1580</fpage><lpage>1592</lpage><pub-id pub-id-type="doi">10.1038/s41564-022-01208-7</pub-id><pub-id pub-id-type="pmid">36097170</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rustad</surname><given-names>TR</given-names></name><name><surname>Sherrid</surname><given-names>AM</given-names></name><name><surname>Minch</surname><given-names>KJ</given-names></name><name><surname>Sherman</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Hypoxia: a window into <italic>Mycobacterium tuberculosis</italic> latency</article-title><source>Cellular Microbiology</source><volume>11</volume><fpage>1151</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2009.01325.x</pub-id><pub-id pub-id-type="pmid">19388905</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savitskaya</surname><given-names>A</given-names></name><name><surname>Nishiyama</surname><given-names>A</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Tateishi</surname><given-names>Y</given-names></name><name><surname>Ozeki</surname><given-names>Y</given-names></name><name><surname>Nameta</surname><given-names>M</given-names></name><name><surname>Kon</surname><given-names>T</given-names></name><name><surname>Kaboso</surname><given-names>SA</given-names></name><name><surname>Ohara</surname><given-names>N</given-names></name><name><surname>Peryanova</surname><given-names>OV</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>C-terminal intrinsically disordered region-dependent organization of the mycobacterial genome by a histone-like protein</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>8197</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-26463-9</pub-id><pub-id pub-id-type="pmid">29844400</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaban</surname><given-names>AK</given-names></name><name><surname>Gebretsadik</surname><given-names>G</given-names></name><name><surname>Hakamata</surname><given-names>M</given-names></name><name><surname>Takihara</surname><given-names>H</given-names></name><name><surname>Inouchi</surname><given-names>E</given-names></name><name><surname>Nishiyama</surname><given-names>A</given-names></name><name><surname>Ozeki</surname><given-names>Y</given-names></name><name><surname>Tateishi</surname><given-names>Y</given-names></name><name><surname>Nishiuchi</surname><given-names>Y</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Ohara</surname><given-names>N</given-names></name><name><surname>Okuda</surname><given-names>S</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Mycobacterial DNA-binding protein 1 is critical for BCG survival in stressful environments and simultaneously regulates gene expression</article-title><source>Scientific Reports</source><volume>13</volume><elocation-id>14157</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-023-40941-9</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P</given-names></name><name><surname>Markiel</surname><given-names>A</given-names></name><name><surname>Ozier</surname><given-names>O</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><name><surname>Ramage</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Schwikowski</surname><given-names>B</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title><source>Genome Research</source><volume>13</volume><fpage>2498</fpage><lpage>2504</lpage><pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id><pub-id pub-id-type="pmid">14597658</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Carette</surname><given-names>X</given-names></name><name><surname>Potluri</surname><given-names>L-P</given-names></name><name><surname>Sharp</surname><given-names>JD</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Prisic</surname><given-names>S</given-names></name><name><surname>Husson</surname><given-names>RN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Investigating essential gene function in <italic>Mycobacterium tuberculosis</italic> using an efficient CRISPR interference system</article-title><source>Nucleic Acids Research</source><volume>44</volume><elocation-id>e143</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkw625</pub-id><pub-id pub-id-type="pmid">27407107</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Tokumoto</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A third bacterial system for the assembly of iron-sulfur clusters with homologs in archaea and plastids</article-title><source>The Journal of Biological Chemistry</source><volume>277</volume><fpage>28380</fpage><lpage>28383</lpage><pub-id pub-id-type="doi">10.1074/jbc.C200365200</pub-id><pub-id pub-id-type="pmid">12089140</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tateishi</surname><given-names>Y</given-names></name><name><surname>Minato</surname><given-names>Y</given-names></name><name><surname>Baughn</surname><given-names>AD</given-names></name><name><surname>Ohnishi</surname><given-names>H</given-names></name><name><surname>Nishiyama</surname><given-names>A</given-names></name><name><surname>Ozeki</surname><given-names>Y</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genome-wide identification of essential genes in Mycobacterium intracellulare by transposon sequencing - implication for metabolic remodeling</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>5449</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-62287-2</pub-id><pub-id pub-id-type="pmid">32214196</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tateishi</surname><given-names>Y</given-names></name><name><surname>Ozeki</surname><given-names>Y</given-names></name><name><surname>Nishiyama</surname><given-names>A</given-names></name><name><surname>Miki</surname><given-names>M</given-names></name><name><surname>Maekura</surname><given-names>R</given-names></name><name><surname>Fukushima</surname><given-names>Y</given-names></name><name><surname>Nakajima</surname><given-names>C</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Comparative genomic analysis of Mycobacterium intracellulare: implications for clinical taxonomic classification in pulmonary Mycobacterium avium-intracellulare complex disease</article-title><source>BMC Microbiology</source><volume>21</volume><elocation-id>103</elocation-id><pub-id pub-id-type="doi">10.1186/s12866-021-02163-9</pub-id><pub-id pub-id-type="pmid">33823816</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tateishi</surname><given-names>Y</given-names></name><name><surname>Ozeki</surname><given-names>Y</given-names></name><name><surname>Nishiyama</surname><given-names>A</given-names></name><name><surname>Miki</surname><given-names>M</given-names></name><name><surname>Maekura</surname><given-names>R</given-names></name><name><surname>Kida</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Virulence of Mycobacterium intracellulare clinical strains in a mouse model of lung infection - role of neutrophilic inflammation in disease severity</article-title><source>BMC Microbiology</source><volume>23</volume><elocation-id>94</elocation-id><pub-id pub-id-type="doi">10.1186/s12866-023-02831-y</pub-id><pub-id pub-id-type="pmid">37009882</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tateishi</surname><given-names>Y</given-names></name><name><surname>Nishiyama</surname><given-names>A</given-names></name><name><surname>Ozeki</surname><given-names>Y</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Construction of knockout mutants in Mycobacterium intracellulare ATCC13950 strain using a thermosensitive plasmid containing negative selection marker rpsL</article-title><source>Microbiology and Immunology</source><volume>68</volume><fpage>339</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1111/1348-0421.13167</pub-id><pub-id pub-id-type="pmid">39041356</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tortoli</surname><given-names>E</given-names></name><name><surname>Meehan</surname><given-names>CJ</given-names></name><name><surname>Grottola</surname><given-names>A</given-names></name><name><surname>Fregni Serpini</surname><given-names>G</given-names></name><name><surname>Fabio</surname><given-names>A</given-names></name><name><surname>Trovato</surname><given-names>A</given-names></name><name><surname>Pecorari</surname><given-names>M</given-names></name><name><surname>Cirillo</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genome-based taxonomic revision detects a number of synonymous taxa in the genus Mycobacterium</article-title><source>Infection, Genetics and Evolution</source><volume>75</volume><elocation-id>103983</elocation-id><pub-id pub-id-type="doi">10.1016/j.meegid.2019.103983</pub-id><pub-id pub-id-type="pmid">31352146</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchiya</surname><given-names>K-I</given-names></name><name><surname>Tomida</surname><given-names>S</given-names></name><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Asahi</surname><given-names>S</given-names></name><name><surname>Nikai</surname><given-names>T</given-names></name><name><surname>Ogawa</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Comparative genome analyses of Mycobacterium avium reveal genomic features of its subspecies and strains that cause progression of pulmonary disease</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>39750</elocation-id><pub-id pub-id-type="doi">10.1038/srep39750</pub-id><pub-id pub-id-type="pmid">28045086</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Opijnen</surname><given-names>T</given-names></name><name><surname>Camilli</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transposon insertion sequencing: a new tool for systems-level analysis of microorganisms</article-title><source>Nature Reviews Microbiology</source><volume>11</volume><fpage>435</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3033</pub-id><pub-id pub-id-type="pmid">23712350</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Via</surname><given-names>LE</given-names></name><name><surname>Lin</surname><given-names>PL</given-names></name><name><surname>Ray</surname><given-names>SM</given-names></name><name><surname>Carrillo</surname><given-names>J</given-names></name><name><surname>Allen</surname><given-names>SS</given-names></name><name><surname>Eum</surname><given-names>SY</given-names></name><name><surname>Taylor</surname><given-names>K</given-names></name><name><surname>Klein</surname><given-names>E</given-names></name><name><surname>Manjunatha</surname><given-names>U</given-names></name><name><surname>Gonzales</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>EG</given-names></name><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>Raleigh</surname><given-names>JA</given-names></name><name><surname>Cho</surname><given-names>SN</given-names></name><name><surname>McMurray</surname><given-names>DN</given-names></name><name><surname>Flynn</surname><given-names>JL</given-names></name><name><surname>Barry</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates</article-title><source>Infection and Immunity</source><volume>76</volume><fpage>2333</fpage><lpage>2340</lpage><pub-id pub-id-type="doi">10.1128/IAI.01515-07</pub-id><pub-id pub-id-type="pmid">18347040</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Zimmermann</surname><given-names>M</given-names></name><name><surname>Goodwin</surname><given-names>MB</given-names></name><name><surname>Sauer</surname><given-names>U</given-names></name><name><surname>Barry</surname><given-names>CE</given-names></name><name><surname>Boshoff</surname><given-names>HI</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Fumarate reductase activity maintains an energized membrane in anaerobic <italic>Mycobacterium tuberculosis</italic></article-title><source>PLOS Pathogens</source><volume>7</volume><elocation-id>e1002287</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002287</pub-id><pub-id pub-id-type="pmid">21998585</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>E</given-names></name><name><surname>Roe</surname><given-names>F</given-names></name><name><surname>Bugnicourt</surname><given-names>A</given-names></name><name><surname>Franklin</surname><given-names>MJ</given-names></name><name><surname>Heydorn</surname><given-names>A</given-names></name><name><surname>Molin</surname><given-names>S</given-names></name><name><surname>Pitts</surname><given-names>B</given-names></name><name><surname>Stewart</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Stratified growth in <italic>Pseudomonas aeruginosa</italic> biofilms</article-title><source>Applied and Environmental Microbiology</source><volume>70</volume><fpage>6188</fpage><lpage>6196</lpage><pub-id pub-id-type="doi">10.1128/AEM.70.10.6188-6196.2004</pub-id><pub-id pub-id-type="pmid">15466566</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Zhong</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>N</given-names></name><name><surname>Ma</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Yue</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>Q</given-names></name><name><surname>Sheng</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pan-Genomic study of <italic>Mycobacterium tuberculosis</italic> reflecting the primary/secondary genes, generality/individuality, and the interconversion through copy number variations</article-title><source>Frontiers in Microbiology</source><volume>9</volume><elocation-id>1886</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2018.01886</pub-id><pub-id pub-id-type="pmid">30177918</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.99426.5.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Singh</surname><given-names>Amit</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Indian Institute of Science</institution><country>India</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>This study makes a <bold>valuable</bold> contribution by elucidating the genetic determinants of growth and fitness across multiple clinical strains of Mycobacterium intracellulare, an understudied non-tuberculous mycobacterium. Using transposon sequencing (Tn-seq), the authors identify a core set of 131 genes essential for bacterial adaptation to hypoxia, providing a <bold>convincing</bold> foundation for anti-mycobacterial drug discovery.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.99426.5.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this descriptive study, Tateishi et al. report a Tn-seq based analysis of genetic requirements for growth and fitness in 8 clinical strains of Mycobacterium intracellulare (Mi), and compare the findings with a type strain ATCC13950. The study finds a core set of 131 genes that are essential in all nine strains, and therefore are reasonably argued as potential drug targets. Multiple other genes required for fitness in clinical isolates have been found to be important for hypoxic growth in the type strain.</p><p>Strengths:</p><p>The study has generated a large volume of Tn-seq datasets of multiple clinical strains of Mi from multiple growth conditions, including from mouse lungs. The dataset can serve as an important resource for future studies on Mi, which despite being clinically significant, remains a relatively understudied species of mycobacteria.</p><p>Weaknesses:</p><p>The primary claim of the study that the clinical strains are better adapted for hypoxic growth is yet to be comprehensively investigated. However, this reviewer thinks such an investigation would require a complex experimental design and perhaps form an independent study.</p><p>Comments on revisions:</p><p>The revised paper has satisfactorily addressed my previous concerns, and I have no further issues with this paper.</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.99426.5.sa2</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tateishi</surname><given-names>Yoshitaka</given-names></name><role specific-use="author">Author</role><aff><institution>Niigata University</institution><addr-line><named-content content-type="city">Niigata</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Ozeki</surname><given-names>Yuriko</given-names></name><role specific-use="author">Author</role><aff><institution>Niigata University</institution><addr-line><named-content content-type="city">Niigata</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Nishiyama</surname><given-names>Akihito</given-names></name><role specific-use="author">Author</role><aff><institution>Niigata University School of Medicine</institution><addr-line><named-content content-type="city">Niigata</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Morishige</surname><given-names>Yuta</given-names></name><role specific-use="author">Author</role><aff><institution>Institute of Tuberculosis, Japan</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Minato</surname><given-names>Yusuke</given-names></name><role specific-use="author">Author</role><aff><institution>Fujita Health University</institution><addr-line><named-content content-type="city">Nagoya</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Baughn</surname><given-names>Anthony David</given-names></name><role specific-use="author">Author</role><aff><institution>University of Minnesota</institution><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Matsumoto</surname><given-names>Sohkichi</given-names></name><role specific-use="author">Author</role><aff><institution>Niigata University School of Medicine</institution><addr-line><named-content content-type="city">Niigata</named-content></addr-line><country>Japan</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the previous reviews</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public review) :</bold></p><p>Comments on revisions:</p><p>The revised manuscript has responded to the previous concerns of the reviewers, albeit modestly. The overemphasis on hypoxic adaptation of the clinical isolates persist as a key concern in the paper. The authors have compared the growth-curve of each of the clinical and ATCC strains under normal and hypoxic conditions (Fig. 8), but don't show how mutations in some of the genes identified in Tn-seq would impact the growth phenotype under hypoxia. They largely base their arguments on previously published results.</p><p>As I mentioned previously, the paper will be better without over-interpreting the TnSeq data in the context of hypoxia.</p></disp-quote><p>Thank you for the comment on the issue of not determining the impact of individual gene mutations identified in TnSeq on the growth phenotypes under hypoxia.</p><p>We agree that the lack of validation of TnSeq results is a limitation of this study. Without evidence of growth pattern of each gene-deletion mutant under hypoxia there might be a risk of over-interpretating the data, even though the data are carefully interpreted based on previous reports. We consider that it is necessary to confirm the phenomenon by using knockout mutants.</p><p>We have just recently succeeded in constructing the vector plasmids for making knockout mutants of <italic>M intracellulare</italic> (Tateishi. Microbiol Immunol. 2024). We will proceed to the validation experiment of TnSeq-hit genes by constructing knockout mutants. We already mentioned this point as a limitation of this study in the Discussion (pages 35-36 lines 630-640 in the revised manuscript).</p><p>Reference.</p><p>Tateishi, Y., Nishiyama, A., Ozeki, Y. &amp; Matsumoto, S. Construction of knockout mutants in <italic>Mycobacterium intracellulare</italic> ATCC13950 strain using a thermosensitive plasmid containing negative selection marker <italic>rpsL+</italic>. <italic>Microbiol Immunol</italic> 68, 339-347 (2024).</p><disp-quote content-type="editor-comment"><p>Other points:</p><p>The y-axis legends of plots in Fig.8c are illegible.</p></disp-quote><p>Following the comment, we have corrected Figure 8c and checked the uploaded PDF</p><disp-quote content-type="editor-comment"><p>The statements in lines 376-389 are convoluted and need some explanation. If the clinical strains enter the log phase sooner than ATCC strain under hypoxia, then how come their growth rates (fig. 8c) are lower? Aren't they expected to grow faster?</p></disp-quote><p>Thank you for the comment on the interpretation of the difference in bacterial growth under hypoxia between MAC-PD strains and the ATCC type strain. The growth curve consists of the onset of logarithmic growth and its growth speed. In this study, we evaluated the former as timing of midpoint and the latter as growth rate at midpoint. Timing of midpoint and growth rate at midpoint are individual parameters. The early entry to log-phase does not mean the fast growth rate at midpoint.</p><p>Our results demonstrated that 5 (M.i.198, M.i.27, M003, M019 and M021) out of 8 clinical MAC-PD strains entered log-phase early and continued to grow logarithmically long time (slow growth). This data suggests the capacity for MAC-PD to continue replication long time under hypoxic conditions. By contrast, the ATCC type strain showed delayed onset of logarithmic growth caused by long-term lag phase. The duration of logarithmic growth was short even once after it started. The log phase soon transited to the stationary phase. This data suggests the lower capacity for the ATCC strain to continue replication under hypoxic conditions.</p><p>Following the comment, we have added the interpretation of the growth curve pattern as follows (page 22 lines 379-392 in the revised manuscript): “The growth rate at midpoint under hypoxic conditions was significantly lower in these 5 clinical MAC-PD strains than in ATCC13950. The early entry to log phase followed by long-term logarithmic growth (slow growth rate at midpoint) suggests the capacity for these 5 clinical MAC-PD strains to continue replication long time under hypoxic conditions. On the other hand, the rest 3 clinical MAC-PD strains (M018, M001 and MOTT64) did not show significant change in the growth rate between aerobic and hypoxic conditions, suggesting that there are different levels of capacity in maintaining long-term replication under hypoxia among clinical MAC-PD strains. In ATCC13950, the entry to log phase was significantly delayed under 5% oxygen compared to aerobic conditions, and the growth rate at midpoint was significantly increased under hypoxic conditions compared to aerobic conditions in ATCC13950. Such long-term lag phase followed by short-term log phase suggests lower capacity for ATCC13950 to continue replication under hypoxic conditions compared to clinical MAC-PD strains.”</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #4 (Public review):</bold></p><p>Comments on revisions:</p><p>The revised version has satisfactorily addressed my initial comments in the discussion section.</p></disp-quote><p>The authors thank the Reviewer for understanding our reply.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #5 (Public review):</bold></p><p>Comments on revisions:</p><p>There is quite a lot of data and this could have been a really impactful study if the authors had channelized the Tn mutagenesis by focusing on one pathway or network. It looks scattered. However, from the previous version, the authors have made significant improvements to the manuscript and have provided comments that fairly address my questions.</p></disp-quote><p>The authors thank the Reviewer for understanding our reply. And the authors thank the Reviewer for the comments suggesting the future studies of TnSeq that focus on one pathway or network.</p></body></sub-article></article>